Abstract
Background and objectives: There are concerns with the current prescribing practices of antibiotics in ambulatory care in Tanzania, including both the public and private sectors. These concerns need to be addressed as part of the national action plan (NAP) of Tanzania to reduce rising antimicrobial resistance (AMR) rates. Issues and concerns include high rates of prescribing of antibiotics for essentially self-limiting conditions. Consequently, there is a need to address this. As a result, the aims of this narrative review were to comprehensively summarize antibiotic utilization patterns particularly in ambulatory care and their rationale in Tanzania and to suggest ways forward to improve future prescribing practices. Materials and Methods: We undertook a narrative review of recently published studies and subsequently documented potential activities to improve future prescribing practices. Potential activities included instigating quality indicators and antimicrobial stewardship programs (ASPs). Results: Published studies have shown that antibiotics are being excessively prescribed in ambulatory care in Tanzania, in up to 95% to 96.3% of presenting cases depending on the sector. This is despite concerns with their appropriateness. High rates of antibiotic prescribing are not helped by variable adherence to current treatment guidelines. There have also been concerns with extensive prescribing of ‘Watch’ antibiotics in the private sector. Overall, the majority of antibiotics prescribed across the sectors, albeit inappropriately, were typically from the ‘Access’ group of antibiotics in the AWaRe (Access/Watch/Reserve) classification rather than ‘Watch’ antibiotics to limit AMR. The inappropriate prescribing of antibiotics in ambulatory care is linked to current knowledge regarding antibiotics, AMR, and ASPs among both prescribers and patients. Recommended activities for the future include improved education for all groups, the instigation of updated quality indicators, and the regular monitoring of prescribing practices against agreed-upon guidelines and indicators. Education for healthcare professionals on ASPs should start at undergraduate level and continue post qualification. Community advocacy on the rational use of antibiotics should also include social media activities to dispel misinformation. Conclusion: The quality of current prescribing practices of antibiotics in ambulatory care is sub-optimal in Tanzania. This needs to be urgently addressed.
Keywords: antibiotic prescribing practices, ambulatory care, antimicrobial resistance, antimicrobial stewardship programs, AWaRe classification, national action plans, quality indicators, Tanzania
1. Introduction
Antimicrobial resistance (AMR) is an increasing public health concern, with some authors suggesting that AMR could be the next pandemic unless actively addressed through a range of initiatives and measures [1]. In 2019, it was estimated that, globally, there were 1.27 million deaths directly attributable to bacterial AMR, with potentially up to 4.95 million deaths associated with bacterial AMR [2]. AMR is also associated with considerable morbidity and costs [3,4,5,6,7]. The World Bank estimated that the costs of AMR could be as high as USD 3.4 trillion annually unless addressed, which is equivalent to 3.8% of the annual global gross domestic product [4]. A number of national and international initiatives have now taken place to try and reduce AMR. International initiatives include the World Health Organization’s (WHO) Global Action Plan (GAP) [8], which has translated into national action plans (NAPs) (Table S1) [9,10]. There are also regional initiatives across Africa to improve the surveillance of infectious diseases and resistance patterns as well as to develop guidelines [11,12,13,14,15]. These combined activities are critical in sub-Saharan Africa, which currently has the highest burden of AMR globally [2,16].
However, African countries are at different stages of the introduction and monitoring of their NAPs due to multiple challenges [17,18]. Challenges within sub-Saharan Africa include limited resources and personnel, including champions, to drive forward agreed-upon activities [9,17,19,20].
Recently, the WHO has reclassified antibiotics into a proposed AWaRe classification (Access, Watch, and Reserve), as well as launched the AWaRe book, which includes management suggestions for 26 common or severe clinical syndromes to reduce AMR [21,22,23]. The AWaRe book, with its classification of antibiotics, takes into account the impact of different antibiotics and their resistance potential to reduce AMR [21,22,24]. According to this system, antibiotics in the ‘Watch’ group should be carefully considered before being prescribed, whilst those in the ‘Reserve’ group should only be prescribed as a last resort in hospitals and prioritized for antimicrobial stewardship programs (ASPs) [21,23,25].
In recent years, various national and other groups have been active in Tanzania to improve the utilization of antibiotics (Table 1) and to reduce AMR rates given rising concerns regarding AMR in both hospital and ambulatory care in Tanzania (Table 2) [26]. At one stage, it was estimated that by the end of 2022, total antibiotic utilization in Tanzania would be 13 times higher than that in 2010, an appreciable proportion of which was likely to be inappropriate [27]. Encouragingly, recent studies have suggested an appreciable decrease in national antimicrobial utilization rates in the human sector in Tanzania between 2017 and 2019 influenced by ongoing activities (Table 1) [26,28].
Table 1.
Group | Activities and Achievements | References |
---|---|---|
Ministry of Health and others—NAP and Guidelines |
|
[26,29,30,31,32,33,34] |
Ministry of Health and others—ehealth strategy (2013–2018)/star rating system |
|
[35,36,37,38,39] |
Medicines, Technologies, and Pharmaceutical Services (MtaPS) program in hospitals |
|
[40,41] |
Commonwealth Pharmacist Association |
|
[42] |
Table 2.
Sector/Setting | Author, Year, and References | Key Findings |
---|---|---|
Multiple sites across Tanzania (10 studies) | Camara et al., 2023 [32] |
|
Hospital | Joachim et al., 2017 [43] |
|
Mikomangwa et al., 2020 [44] |
|
|
Silago et al., 2020 [45] |
Out of 91 isolates from patients admitted with osteomyelitis to a tertiary hospital, 85.1% of isolates were S. aureus, of which 28.6% were confirmed as MRSA strains. | |
Mnyambwa et al., 2021 [46] |
|
|
Moremi et al., 2021 [47] |
|
|
Mloka et al., 2022 [48] |
|
|
Ambulatory care | Gidabayda et al., 2017 [49] |
|
Msanga et al., 2022 [50] |
|
|
Schmeider et al., 2022 [51] |
|
|
Silago et al., 2022 [52] |
|
|
Mlugu et al., 2023 [53] |
|
NB: ESBL-GNB = extended-spectrum beta-lactamases producing Gram-negative bacilli; MDR = multidrug-resistant; MIC = minimum inhibitory concentration; MRSA = methicillin-resistant Staphylococcus aureus; P. aeruginosa = Pseudomonas aeruginosa; UTI = urinary tract infection.
There are also concerns currently with the suboptimal registration of essential antimicrobials in Tanzania, alongside the excessive registration of non-essential antimicrobials [54]. In addition, concerns with the availability of unnecessary fixed-dose combinations (FDCs) of antibiotics in the Essential Medicines List in Tanzania, which increases the risk of side effects and AMR [10,55]. These FDCs include the ampicillin–cloxacillin, flucloxacillin–amoxicillin, and ceftriaxone–sulbactam combinations [55]. Both these areas need addressing going forward. However, initially, a critical area for all key stakeholders in Tanzania to concentrate on in order to improve antibiotic use, thereby reducing AMR, is ambulatory care. This is because ambulatory care can account for up to 90–95% of total human antibiotic use in countries, especially in low- and middle-income countries (LMICs) [22,56,57,58]. In addition, there have been increasing concerns regarding the irrational prescribing of antibiotics among healthcare professionals (HCPs) in Tanzania, including for the management of diarrhea and respiratory illnesses in children, enhancing AMR [59,60,61,62,63]. AMR is further exacerbated in Tanzania by antibiotics being widely available and used without a prescription (Table S2) [59,64,65,66,67,68,69], enhanced by issues of affordability and convenience [59]. For instance, in their study among 59 LMICs, Hossain et al. (2023) found that only 22.4% of children in Tanzania with either a cough or fever received antibiotics from qualified sources, e.g., recognized hospitals and clinics [70]. Alongside this, the appreciable availability of left-over antibiotics in households, coupled with their ease of availability in community pharmacies and drug stores, has resulted in delays in parents seeking professional help to treat young children with community acquired pneumonia (CAP) [71]. In addition, there has been mass drug administration of azithromycin for trachoma control in Tanzania, potentially impacting on AMR [72,73]. These concerns and issues are enhanced by the appreciable prevalence of acute respiratory illnesses (ARIs) among children under five being treated at health facilities in Tanzania (85%) [74], as well as the promotional activities of pharmaceutical companies [75,76].
These issues and concerns are important, with Fink et al. (2020) finding that the mean number of antibiotics prescribed per sick child visiting a healthcare facility in Tanzania was 0·69 [77], similar to the overall total among eight participating LMICs, including six from Africa [77]. In addition, there was a high rate of prescribing of antibiotics in these children at 61% of attending patients, which is higher than the findings in Rwanda and Congo (58% each) as well as Gabon (50.0%) [74]. Having said this, in their recent systematic review, Acam et al. (2023) found that the extent of antimicrobial utilization in Tanzania, at 40% of encounters, was lower than those in Ethiopia (63%), Sudan (62%), and Kenya (54%) [78].
ASPs have been successfully introduced across LMICs, including among African countries, to improve future antimicrobial prescribing practices. This is despite the many challenges and concerns including necessary financial resources and personnel [79,80,81,82,83,84,85,86,87]. These include ASPs being introduced in Tanzania to improve future antibiotic prescribing practices [88,89], typically starting with a situational analysis [90]. ASPs instigated to date in Tanzania include assessing point-of-care testing as well as developing algorithms to improve antibiotic prescribing practices in ambulatory care [91,92,93]. This is because limited sensitivity testing is currently being performed outside of hospitals in Tanzania.
Other ongoing activities to improve antibiotic use in Tanzania include general strengthening of antimicrobial stewardship (AMS) in the country, building on the Medicines, Technologies, and Pharmaceutical Services (MtaPS) program [40,41], with strengthening ASPs in hospitals being a key element of the 2023 to 2028 NAPs [26] (Table 1). Apps have also been developed to improve the awareness of AMS among HCPs [88].
In view of the ongoing activities to improve antibiotic prescribing practices in ambulatory care in Tanzania (Table 1), alongside ongoing challenges and concerns including high AMR rates (Table 2), there is an urgent need to consolidate current knowledge regarding antibiotic prescribing practices in ambulatory care to provide future direction. This includes both the public and private ambulatory care sectors as there can be appreciable differences in prescribing habits between the sectors. In Botswana, an appreciable number of patients with upper respiratory tract infections (URTIs) are being treated by private physicians, often inappropriately with antibiotics (72.9% of patients) [94]. This is very different to patients being treated in the public system in Botswana, where in addition to patients presenting with coughs, an appreciable number also presented with sexually transmitted infections and vaginal discharges. This resulted in the appreciable prescribing of metronidazole among public HCPs in Botswana, which was very different from that in the private sector [94,95]. In Iran, the same physicians treated patients differently depending on whether they were seen in public versus private sector clinics [96]. Differences between the sectors have also been seen in Tanzania, with the greatest consumption of antimicrobials currently in the private versus public sectors [27,28]. In their study, Kamuhabwa et al. (2015) found that textbooks and the internet were the principal sources of prescribing information for physicians in the public sector, whilst in private healthcare facilities, physicians were more concerned with the proven effectiveness of prescribed medicines [97]. Physicians in the public sector were also more concerned with the costs of medicines as well as their availability compared with those in the private sector [97]. Private health facilities may also be more profit-oriented than public facilities [75], with the potential for providing unnecessary care [98]. Irunde et al. (2017) also found greater rationality in the prescribing practices of medicines in public versus private healthcare facilities [61]. The recent government’s star rating facility quality assessment program, which included both public and private healthcare facilities (Table 1), documented appreciable improvements in both sectors [37,38,99]. However, private for-profit ownership was associated with a 29% lower probability of a lesser improvement versus public facilities [37].
We are also aware that there can be concerns with the availability and distribution of public healthcare facilities especially in rural areas in Tanzania [100]. Alongside this, the current use of prescribing and quality indicators also needs to be comprehensively documented as these can form part of future quality improvement programs including ASPs, especially with ASPs promoted in the updated NAP [26]. ASPs in ambulatory care are likely to increasingly include improved diagnostic tools to reduce inappropriate prescribing of antibiotics in ambulatory care [101].
The principal objectives of this paper are, firstly, to document current prescribing patterns for antibiotics in ambulatory care and their rationale; secondly, to determine key activities to improve future prescribing practices including ongoing prescribing indicators and ASPs; and thirdly, to use the consolidated findings to suggest future activities that can be undertaken by all key stakeholder groups in the short to medium term to improve future antibiotic prescribing in ambulatory care in Tanzania thereby reducing AMR. This includes any research activities as part of ongoing developments to enhance implementation research in Tanzania [102]. We have concentrated on ambulatory care prescribing versus in-patient prescribing since, as mentioned, up to 95% of total antibiotic utilization in humans in LMICs occurs in ambulatory care [56]. Consequently, it is a critical element of a one-health approach to reducing AMR in Tanzania.
2. Materials and Methods
2.1. Our Approach and Key Questions
We principally used a narrative review to address the objectives of this paper. This review involved answering the following questions with the ultimate aim of reducing AMR in Tanzania through the improved prescribing of antibiotics in ambulatory care [83,103,104,105]:
What have been the prescribing patterns of antibiotics in public ambulatory care settings in Tanzania in recent years?
What have been the prescribing patterns of antibiotics in the ambulatory care private sector in Tanzania in recent years?
What is the knowledge, attitude, and practices (KAP) towards antibiotics, AMR, and ASPs among key stakeholder groups involved in ambulatory care prescribing practices in Tanzania in recent years?
What prescribing and quality indicators have been used in ambulatory care settings across the sectors in Tanzania in recent years to improve the appropriateness of prescribing practices?
What ASPs, including their impact, have been instigated in ambulatory care in Tanzania in recent years to improve future antibiotic prescribing practices? In addition, what guidance can other LMICs provide to key stakeholder groups in Tanzania through their activities?
What potential activities could be instigated by key stakeholder groups in Tanzania, including the Ministry of Health, health insurance groups, physician groups, universities, and patient groups, in the short to medium terms to improve the appropriateness of antibiotic prescribing practices across the ambulatory care sectors in Tanzania to reduce AMR?
A narrative review approach was identified as the most appropriate approach to achieve the objectives of this paper. The motivation being that this approach allows for a broader scope compared to a systematic review as a number of potential papers may not be listed in PubMed or Web of Science; however, they can provide useful insights into current activities in Tanzania. In addition, pertinent information contained within a paper may be part of a wider paper, which could be missed during a systematic review. This includes knowledge of antibiotics and AMR among patients seeking help from community pharmacies without seeking any help from HCPs in ambulatory care facilities.
We were also aware that there have been a number of reviews of various factors influencing the prescription of antibiotics in ambulatory care settings in recent years including Tanzania and beyond. In addition, there have been reviews discussing potential activities to reduce the inappropriate prescribing of antibiotics in ambulatory care. However, most studies have typically focused on higher-income countries where resources and personnel can be very different [77,78,79,83,104,106,107,108,109]. Alongside this, typically only focused on one key area such as prescribing practices in ambulatory care clinics or ASPs. As a result, making it challenging to bring together all the key aspects associated with improving the appropriateness of antibiotic prescribing practices in ambulatory care settings into one comprehensive review. This was the philosophy behind this approach.
A narrative review also gives more flexibility and greater coverage of the relevant literature to provide future direction to all key stakeholder groups, similar to our recent paper in South Africa [110]. We are aware though that there are limitations with this approach in terms of rigor. However, to minimize bias, as well as to help ensure all relevant information is included in this narrative review, the participating co-authors have considerable experience in Tanzania, across Africa and beyond, in terms of research and practice surrounding the prescribing of antibiotics in ambulatory care as well as implementing policies to improve appropriate prescribing practices. This is seen as particularly important when recommending future activities to improve the prescribing of antibiotics in Tanzanian ambulatory care, which is a key objective of the paper.
We adopted a similar approach in South Africa and other LMICs when documenting and suggesting activities to improve the care of patients with both infectious and non-infectious diseases. Alongside this, documenting challenges with implementing NAPs and ASPs across sectors in Africa to reduce AMR and potential ways to address these [17,84,111,112,113,114,115]. Consequently, we were confident that this would be an appropriate approach for this comprehensive review.
2.2. Search Strategy and Inclusion Criteria
A literature search was performed to address the six identified questions using a number of databases including PubMed/MEDLINE, Web of Science, and Google Scholar. In addition, we conducted a manual search of the grey literature, which included key Ministry of Health documents including any NAPs.
The search strategy, which was used to address the identified questions, included a number of search terms. The search terms were ambulatory care; antibiotics; antibiotic prescribing; antimicrobials; antimicrobial prescribing; antimicrobial stewardship; antimicrobial stewardship programs; guidelines; low- and middle-income countries; prescribing indicators; quality indicators; private healthcare facilities; public healthcare centers; and Tanzania.
In view of the possible scarcity of published literature with respect to the six key questions identified, the qualifying criteria were purposefully broad. However, only English language papers were sourced as English is the recognized international scientific language [110].
We also only concentrated on ambulatory care settings as this is where the majority of patients with infections such as URTIs are treated if they visit healthcare facilities across Africa, including Tanzania. In addition, this approach acknowledges the increasing adoption of digital technologies in ambulatory care in Tanzania as well as ongoing moves to improve ambulatory care [35,93] (Table 1).
Alongside this, we also only concentrated on documented studies from 2016 onwards to reflect improvements in digitalization and other aspects of care to improve the management of patients with infectious diseases in Tanzania in recent years (Table 1) [35]. We are aware that some research was conducted appreciably earlier than 2016 but only reported recently, e.g., the study of Wiedenmayer et al. was conducted in 2012; however, only published in 2021 [116]. Alongside this, some systematic reviews including Tanzania published in recent years included studies published in 1993, which is a concern when attempting to analyze current prescribing practices and their implications [78]. However, we were cognizant of this when making suggestions for the future. We were also aware of the excessive prescribing of antibiotics in patients with COVID-19 since the start of the pandemic among LMICs, including Tanzania, despite limited evidence of secondary infections or bacterial co-infections [117,118,119,120,121,122,123]. This has been exacerbated in Tanzania by poor adherence to infection, prevention, and control (IPC) compliance to measures surrounding COVID-19 among healthcare workers in ambulatory care [124]. In addition, antibiotics were being included in national treatment guidelines across Africa despite COVID-19 being a viral infection [125]. We wanted to reflect whether this is still the case in sourced publications.
Achieving appropriate antibiotic prescribing practices in ambulatory care settings is a critical part of achieving the goals of the NAP to reduce AMR in Tanzania. Consequently, it is important that possible interventions are initially prioritized in ambulatory care, as opposed to hospital care, especially since the emphasis on research to date to document and improve antibiotic prescribing practices including ASPs has typically been on hospital care across Africa, including Tanzania and other LMICs [84,86,87,88,89,90,126]. This includes the strengthening of AMS in Tanzania under the Medicines, Technologies, and Pharmaceutical Services (mTaPS) program (2018–2023) (Table 1) [40,127].
2.3. Documentation Strategy and Suggestions for the Future
All documented studies will include the authors, the publication year, a summary of the aims and methodology, as well as the key findings. In addition, whether the ambulatory care setting included either public or private facilities or both will be acknowledged. This is because, as mentioned, we are aware that prescribing patterns may vary across the ambulatory care sectors in Tanzania [61,97].
Where possible, we will report antibiotic utilization according to their AWaRe classification: ‘Access’, ‘Watch’, or ‘Reserve’ [21,128]. The ‘Access’ group of antibiotics are considered as first- or second-line antibiotics for a range of common or severe clinical syndromes and typically have a narrow spectrum alongside low resistance potential. The resistance potential and side effects are higher among antibiotics in the ‘Watch’ group; consequently, their prescribing should be carefully considered among HCPs when prescribing these antibiotics. This is in line with recommendations in the AWaRe book [22,23,129]. The ‘Reserve’ group should rarely, if ever, be prescribed in ambulatory care; ideally, these antibiotics should only be prescribed as a last resort in hospitals [21,22,128,129]. The initial target for ‘Access’ antibiotics is 60% of total utilization across sectors; however, this is likely to vary across countries [22,25].
Finally, regarding possible future strategies among the key stakeholder groups, then, as mentioned, we will build on the considerable experience of the co-authors, similar to the situation in South Africa [110].
3. Results
The findings from the narrative review, along with suggested next steps, will be divided into sections. This is in line with the key questions outlined in the Methodology section.
The key components include the following:
Antibiotic prescribing patterns among both public and private ambulatory care settings in Tanzania in recent years;
Knowledge and attitudes towards antibiotics, AMR, and ASPs among all key stakeholder groups involved in prescribing practices in ambulatory care;
Prescribing and quality indicators used in recent years in ambulatory care settings in Tanzania to improve prescribing practices;
Details of any ASPs that have been implemented in ambulatory care settings in Tanzania and beyond in recent years to improve future prescribing practices of antibiotics and their impact, where known;
Potential activities that can be undertaken by all key stakeholder groups in ambulatory care in Tanzania in the short to medium terms to improve future appropriateness of antibiotic prescribing practices, thereby helping to reduce AMR.
3.1. Prescription of Antibiotics in Public Ambulatory Care Facilities in Tanzania
Wiedenmayer et al. (2021), in their study among 120 public facilities, emphasized the importance of managing patients with infectious diseases appropriately in Tanzania with only a limited number of patients (1.2%) presenting with non-communicable diseases (NCDs) [116]. This may be why there has been appreciable prescribing of antibiotics in public ambulatory care facilities in Tanzania (Table 3) despite often limited evidence for their appropriateness [60,130,131,132,133,134]. However, in their study, Acam et al. (2023) ascertained that overall only 40% of patient encounters resulted in an antimicrobial being prescribed [78], which was lower than that among healthcare facilities in Ethiopia (63%), Sudan (62%), and Kenya (54%). Having said this, it is still appreciably higher than the WHO recommendation of 20% of encounters [78].
The high prescribing rates seen in practice in Tanzania may be influenced by fear or worse health outcomes if antibiotics are not prescribed; expectations from patients, especially if they have limited knowledge regarding antibiotics and AMR; as well as the potential influence from pharmaceutical company promotional activities [76,135].
Encouragingly, when antibiotics were prescribed, these were typically from the ‘Access’ list as opposed to the ‘Watch’ list, with little or no evidence of prescriptions antibiotics from the ‘Reserve’ list [131,132,134,136]. This is similar to the findings of Mbwasi et al. (2020), who found that >90% of all antimicrobial consumption in Tanzania, based on import data, was ‘Access’ as opposed to ‘Watch’ and ‘Reserve’ antibiotics [28].
Table 3.
Author, Year, and Setting | Objective/Aim and Methodology | Summary of Key Findings Including the Prescribing of Antibiotics via AWaRe Classification * Where Documented |
---|---|---|
Irunde et al., 2017 [61], exit interviews in randomly selected public and private facilities conducted in 2014 |
|
|
Fink et al., (2020) [77], healthcare facilities in LMICs including Tanzania between May 2006 and December 2016 |
|
|
Emgård et al., 2021 [130], primary HCWs’ experiences via in-depth interviews conducted in 2019 |
|
|
Huth et al., 2021 [131], Pediatric Outpatient Department in a regional referral hospital with patients recruited between August and December 2016 |
|
|
Kilipamwambu et al., 2021 [132], PHC facilities between September 2018 and September 2019 |
|
|
Van de Maat et al., 2021 [133], PHC facilities between December 2014 and February 2016 |
|
|
Wiedenmayer et al., 2021 [116], 120 PHC facilities with the study conducted in 2012 |
|
|
Mabilika et al., 2022 [134], PHC facilities in 2 districts between January 2020 and December 2020 |
|
|
Acam et al., (2023) [78], review of studies conducted in East Africa and published between 1993 and 2017 |
|
|
Ekholuenetale et al., 2023 [74], demographic and health surveys—surveys conducted every 5 years between 2006 and 2021 |
|
|
Keenan et al., 2023 [136], mixed-method study among 3 East African countries including Tanzania between February 2019 and September 2020 |
|
|
Pinto Jimenez et al., 2023 [76], HCPs across Tanzania among six selected countries with data collected in 2018 |
|
|
NB: ARI = acute respiratory tract infection; * AWaRe = Access (A), Watch (W), and Reserve (R) antibiotics [21,128]; FDC = fixed-dose combination; HCP = healthcare professional; HCWs = healthcare workers; LMICs = low- and middle-income countries; PHCs = primary healthcare; URTIs = upper respiratory tract infections; UTIs = urinary tract infections; WHO = World Health Organization.
3.2. Prescription of Antibiotics in Private Ambulatory Care Facilities in Tanzania
Similar to physicians in the public sector, there have been concerns regarding the appropriateness of antibiotic prescribing practices among physicians working in the ambulatory care private sector in Tanzania.
Table 4 summarizes current prescribing practices among physicians working in the private ambulatory care sector. Similar to the situation among public facilities, there has been considerable prescription of antibiotics for self-limiting conditions including URTIs [136,137]. In addition, there has been a general overprovision of care, including unnecessary prescriptions of antibiotics [98,138].
Table 4.
Author, Year, and Setting | Objectives and Methodology | Summary of Key Findings Including the Prescribing of Antibiotics Via AWaRe Classification * Where Documented |
---|---|---|
Irunde et al., 2017 [61], exit interviews in randomly selected public and private facilities conducted in 2014 |
|
|
Rogawski et al., 2017 [63], documented antibiotic use from mothers of children >2 years from 8 countries including Tanzania, study conducted between 2009 and 2019 |
|
|
Khalfan et al., 2021 [139], claims forms from insured patients, study conducted in September 2019 |
|
|
King et al., 2021 and 2023 [98,138], standardized patients (SPs) visiting 227 health facilities—May to June 2018 |
|
|
Khalfan et al., 2022 [140], insured patients—September 2018 |
|
|
King et al., 2022 [137], informed/uninformed standardized patients (SPs) visiting 227 facilities—May to June 2018 |
|
|
Keenan et al., 2023 [136], mixed-method study among outpatients in 3 East African countries including Tanzania between February 2019 and September 2020 |
|
|
NB: ARI = acute respiratory tract infection; * AWaRe = Access (A), Watch (W), and Reserve (R) antibiotics [21,128]; EML = Essential Medicines List; HCP = healthcare professional; HCWs = healthcare workers; LMICs = low- and middle-income countries; NHIF = National Health Insurance Fund; STG = standard treatment guidelines; TB = tuberculosis; URTIs = upper respiratory tract infections; UTIs = urinary tract infections; WHO = World Health Organization.
Of equal concern is the high rate of prescribing of antibiotics from the ‘Watch’ list seen in some studies, which reached up to 33.3% of antibiotics prescribed in one study [98,139]. Having said this, Mbwasi et al. (2020) found that >90% of all antimicrobial consumption in Tanzania, based on import data, was ‘Access’ as opposed to ‘Watch’ and ‘Reserve’ antibiotics, with the most utilization in the private versus public sectors [28]. Encouragingly (Table 4), there appeared to be no prescriptions of antibiotics from the ‘Reserve’ list, which is similar to findings among public ambulatory care facilities in Tanzania (Table 3). In addition, this was similar to the findings of Mbwasi et al., with <1% of imported antibiotics being from the ‘Reserve’ list [28].
3.3. Knowledge and Attitudes Concerning Antibiotics and AMR among Key Stakeholder Groups Involved in Ambulatory Care in Tanzania
There have been concerns with current knowledge and attitudes regarding antibiotics among key stakeholder groups in Tanzania (Table 5). This includes healthcare students, who will become future prescribers and dispensers [141,142].
Issues and concerns identified among the 14 studies in this narrative review, which need to be addressed going forward, include concerns with knowledge and attitudes regarding antibiotics, AMR, and ASPs. This is not helped by currently variable training on antibiotics, AMR, and AMS among universities in Tanzania [76], as well as a lack of sources giving guidance on future prescribing practices. The recently launched AWaRe book giving treatment guidance on a range of infectious diseases found in ambulatory care should help in this regard going forward [22,23]. Future activities could also include upgrading the curricula for HCPs to better equip them with the necessary confidence and skills to improve prescribing across the sectors [75,142,143]. Universities should also upgrade their continuous professional development (CPD) activities to address concerns with the knowledge and practices of HCPs in ambulatory care settings across Tanzania. This is in line with the objectives in the updated NAP of Tanzania (2023 to 2028) [26] and will be part of future suggestions going forward.
Table 5.
Author, Year, and Setting | Aims/Objectives and Methodology |
Key Findings |
---|---|---|
Mbwambo et al., 2017 [144], randomly selected community members |
|
|
Lyimo et al., 2018 [145], HCPs in Northern Tanzania |
|
|
Mboya et al., 2020 [135], patients in Northern Tanzania |
|
|
Simon et al., 2020 [68], parents and guardians of young children in Tanzania |
|
|
Emgård et al., 2021 [130], interviews with HCWs in Tanzania |
|
|
Frumence et al., 2021 [146], structured interviews with key personnel in Tanzania |
|
|
Gabriel et al., 2021 [147], consumers in Ilala Municipality |
|
|
Lubwama et al., 2021 [141], medical and pharmacy students |
|
|
Mutagonda et al., 2022 [148], parents/guardians of children |
|
|
Nkinda et al., 2022 [143], physicians and pharmacists |
|
|
Nkinda et al., 2022 [75], prescribers and dispensers |
|
|
Ogunnigbo et al., 2022 [142], healthcare students |
|
|
Pinto Jimenez et al., 2023 [76], HCPs including Tanzania |
|
|
Virhia et al., 2023 [149], HCPs in Tanzania |
|
|
NB: AMR = antimicrobial resistance; AMS = antimicrobial stewardship; ASPs = antimicrobial stewardship programs; HCPs = healthcare professionals; HCWs = healthcare workers; KAP = knowledge, attitude, and practices.
3.4. Quality Indicators Currently Being Used in Ambulatory Care in Tanzania
A number of prescribing and quality indicators have been used in Tanzania to assess the quality of current antibiotic prescribing practices in ambulatory care across the sectors. These are contained in Table 6. Documented prescribing and quality indicators can be part of future ASPs in Tanzania, with for example adherence to guidelines increasingly seen as providing good quality care in Tanzania and beyond [34,133,134].
Table 6.
Indicator—Activity/Performance | References |
---|---|
Mean number of antibiotics prescribed per patient for a given diagnosis | [63,77] |
% adherence to WHO/INRUD core prescribing indicators, including the number of encounters resulting in antibiotics being prescribed and whether antibiotics prescribed are on the current national EML | [61,78,132] |
% of antibiotics prescribed adhering to current EML or STGs | [116,133,134,139] |
% of non-recommended treatments prescribed | [133] |
% of dosing of antibiotics within agreed ranges | [133] |
% of patients prescribed the wrong medication | [116] |
% of patients over-prescribed antimicrobials | [98,138] |
% of patients prescribed antibiotics for infectious diseases including for respiratory tract infections/febrile illness (assessing over-prescribing) | [91,92,150,151,152] |
% of patients prescribed ‘Watch’ antibiotics as opposed to ‘Access’ antibiotics | [98,137,139] |
Indicator—Outcome | |
% of clinical failures in children with febrile illness | [92,152] |
% Secondary hospitalization or death by day 30 in children aged 2–59 months with fever and cough but without life-threatening conditions | [92] |
NB: EML = Essential Medicine List; STG = standard treatment guidelines.
3.5. Antimicrobial Stewardship/Quality Improvement Programs in Ambulatory Care in Tanzania
Exemplars of ASPs undertaken to date in ambulatory care in Tanzania (Table 7), coupled with those from other LMICs (Supplementary Table S3), can provide directions to all key stakeholder groups as key personnel in Tanzania make progress in the NAP to reduce AMR. Such activities are enhanced by a greater emphasis on ASP activities in the updated NAP [26].
The studies by Rambaud-Althaus et al. (2017), Olaoye et al. (2020), and Ogunnigbo et al. (2022) are important as they discuss the introduction of guidelines on smartphones to improve future antibiotic prescribing practices as the digital environment in Tanzania is improved (Table 1) [35,36,42,142,151]. Alongside this, the government’s star rating facility quality assessment program was introduced for both public and private healthcare facilities (Table 1) [37,38,99]. Such developments are important to be able to monitor prescribing practices against agreed-upon indicators to provide ‘real time’ feedback to prescribers as opposed to irregular reviews of paper-based patient records. Providing real-time feedback on adherence to well-proven, well-communicated, and accepted treatment recommendations has worked well in Stockholm, Sweden, with the ‘Wise List’ [153,154]. Real-time feedback to prescribers, as well as monitoring of their performance compared with their colleagues, have resulted in continued high adherence to suggested treatments in practice over time in Stockholm, providing exemplars to others [153,155].
Table 7.
Author and Year | Setting and Activities | Key Findings Including their Impacts |
---|---|---|
Hopkins et al., 2017 [150] |
|
|
Keitel et al., 2017 [152] |
|
|
Rambaud-Althaus et al., 2017 [151] |
|
|
Keitel et al., 2019 [92] |
|
|
Olaoye et al., 2020 [42] |
|
|
Hogendoorn et al., 2022 [91] |
|
|
King et al., 2021 [156] |
|
|
Ogunnigbo et al., 2022 [142] |
|
|
NB: HCP = healthcare professional; HCW = healthcare worker; LRTIs = lower respiratory tract infections; POCT = point-of-care testing; IPC = infection, prevention, and control; SP = simulated patient; STG = standard treatment guidelines.
3.6. Suggested Activities in the Short to Medium Terms to Reduce Inappropriate Prescription of Antibiotics in Ambulatory Care Settings in Tanzania
Table 8 provides a range of suggestions in the short to medium terms to help improve antibiotic prescribing practices in ambulatory care in both the public and private sectors in Tanzania. This builds on the findings in Table 1, Table 2, Table 3, Table 4, Table 5, Table 6 and Table 7 along with ongoing initiatives, which include the star rating scheme to improve the quality of ambulatory care as well as ongoing AMS educational activities [37,40,41]. In addition, activities are ongoing within the functioning multi-sectoral coordinating committee for AMR activities [31]. As a result, they help to reduce any negative impact of promotional activities among pharmaceutical companies [75,76], which has been a concern in other African countries [157,158,159].
Table 8.
Key Groups | Suggested Activities |
---|---|
Ministry of Health and health insurance groups |
|
Physicians and other associations dealing with ambulatory prescription across sectors |
|
Patients and patient associations, including advocacy groups |
|
4. Discussion
To the best of our knowledge, we believe this is the first study in Tanzania to comprehensively document and review all aspects of antibiotic prescribing practices in ambulatory care across the country, the objective being to lay the foundation for suggested activities to improve future prescribing practices and to reduce AMR. Key aspects of this narrative review included documenting antibiotic prescribing patterns across the sectors in recent years as well as key stakeholder knowledge and perceptions towards antibiotics, AMR, and ASPs. In addition, ongoing activities are needed to improve future antibiotic prescribing in ambulatory care in Tanzania. Proposed activities include building on current quality improvement programs including increased digitalization in ambulatory care, as well as the instigation of prescribing and quality indicators increasingly based on the AWaRe book [22,23]. Such activities can help grow the number of ASPs that have already been undertaken in Tanzania.
The findings in this study highlight considerable issues and concerns regarding the current prescribing practices of antibiotics across the sectors, which can include the excessive prescription of ‘Watch’ antibiotics in private care settings [74,116,134,137,139]. However, encouragingly, this is generally not the case in Tanzania, with import data showing that 83.1% of imported antibiotics in recent years are from the ‘Access’ group versus only 10.1% from the ‘Watch’ group and <0.01% from the ‘Reserve’ group [27]. Limiting the prescribing of ‘Watch’ antibiotics, as well as discouraging the prescribing of any ‘Reserve’ antibiotics in ambulatory care, are an important first step to reducing AMR [21,24]. We have seen high rates of ‘Watch’ antibiotics being dispensed or prescribed in ambulatory care in other LMICs, which needs to be avoided where possible in Tanzania alongside reducing any prescriptions of azithromycin where pertinent [73,174,175,176]. However, encouragingly, this was generally not the case in Tanzania (Table 3 and Table 4). Concerns though with current appreciable prescriptions of antibiotics in ambulatory care in Tanzania, especially for self-limiting conditions such as ARIs and UTIs, needs to be avoided where possible, which is similar to other African countries [110,177,178,179,180,181,182,183].
Key activities to improve future prescribing practices of antibiotics in ambulatory care in Tanzania include improving the evidence base, building on current knowledge (Table 3, Table 4 and Table 5). Alongside this, there are encouraging ongoing efforts to improve digitalization in Tanzania, building on current activities (Table 1), as well as to develop and introduce easy-to-use apps that can provide treatment guidance and improve routine data collection (Table 8). These efforts are essential for the Ministry of Health, as well as Health Insurers, to be able to rapidly monitor the appropriateness of any antibiotics prescribed against agreed-upon guidance, building on agreed-upon prescribing indicators (Table 6). As mentioned, agreed-upon indicators are likely to be increasingly based on the recently launched AWaRe book with its extensive treatment guidance [22,23]. This is because there are concerns with current adherence rates to STGs in Tanzania, which is similar to other African countries [110,178,180,184,185]. Adherence to guidelines will be increasingly seen as a more appropriate marker of the quality of antibiotic prescribing practices in ambulatory care versus current WHO/INRUD criteria [34,161]. Regular monitoring of adherence to agreed-upon guidelines in ‘real time’, with pertinent ASPs instigated where necessary, is essential to improve prescribing practices in this key sector. Without this, it will be difficult to achieve the agreed-upon goals for reducing AMR in the Tanzanian NAP.
There is also a need, alongside activities with prescribers, to improve the knowledge of all key stakeholders regarding antibiotics, AMR, AMS, and ASPs given current concerns (Table 5 and Table 8). However, for the activities to be effective in improving future prescribing and in reducing AMR, a number of coordinated activities and technologies need to be in place, building on the objectives of the recent NAP update [26]. In addition, ASP activities need to be regularly followed up, else their impact may not be sustained [186]. This is because we have seen in practice that disjointed activities often fail to achieve target objectives [64,187,188,189]. Coupled with this, single activities are generally not as effective as multiple activities to achieve target outcomes as part of an ASP [110,114,115,187]. In view of this, it is essential that all key stakeholder groups work together in Tanzania in a coordinated fashion, with prescribing habits regularly monitored and rapidly fed back. As mentioned, this has worked well in Stockholm, Sweden, with the development, communication, and active monitoring of prescribing against the evidence-based ‘Wise list’ of medicines resulting in high adherence rates in practice [153,154,155]. These proposals build on current digital plans and activities in the ambulatory sector in Tanzania to improve future antibiotic prescribing practices (Table 1) [26,35]. Potential digital activities include the instigation of easy-to-use apps to routinely collect and rapidly analyze antibiotic prescribing habits. Alongside this are improved diagnostic tools as well as greater sensitivity testing in ambulatory care in the future, which will be helpful when discussing the appropriate management of essentially self-limiting infections with patients as well as those with proven bacterial infections [101,190].
Ongoing ASPs in Africa, including Tanzania as well as other LMICs (Table 7 and Table S3), can act as exemplars for future ASPs in the ambulatory care settings. We are aware that there have been challenges undertaking ASPs in ambulatory care in LMICs due to personnel and resource challenges [79]; however, this is beginning to change with a number of ASPs now being undertaken in Tanzania and beyond (Table 7 and Table S3). This is essential to improve the appropriateness of future antibiotic prescribing practices in ambulatory care in Tanzania and across Africa if AMR rates are to be reduced in this high-priority region [2,16].
To date, patients and the activities of their organizations have often been a forgotten element in enhancing the appropriateness of future antibiotic prescribing practices across LMICs. However, their role in influencing prescribing practices is increasingly being recognized. Concerns with the current knowledge of patients regarding antibiotics, AMR, and ASPs (Table 5), need to be addressed going forward as part of future activities. As a result, they help to reduce inappropriate requests for antibiotics when seeing HCPs, especially for self-limiting conditions. To enhance the success of future activities with patients, it is essential that key organizations and patients are part of any future communication campaign, including any campaigns via social media (Table 8). This is because we have already seen the negative impact that misinformation surrounding COVID-19 had on medicine utilization patterns across Africa and beyond, which needs to be avoided [117,166,167,168]. Potential activities going forward to reduce AMR in Tanzania are included in Table 8, and we will continue to monitor the situation. Clear and readily accessible information about non-antibiotic management strategies, especially for self-limiting conditions such as ARIs, alongside treatment expectations and the potential risks of inappropriate antibiotic use, should be provided in a phraseology by HCPs and others that will be easily understood by patients to avoid future confusion [170].
We are aware of the limitations of this paper. These include the fact that we did not undertake a full systematic review for the reasons provided. To address this, we have included an appreciable number of published papers and other sources discussing the current situation regarding antibiotic prescribing patterns in ambulatory care across Tanzania, the rationale for the patterns seen, as well as potential activities among all key stakeholder groups moving forward. The latter has been achieved with considerable input from senior-level co-authors from Tanzania, across Africa and beyond. In addition, we concentrated only on ambulatory care and not hospital care for the reasons stated. Despite these limitations, we believe our findings and suggestions for the future are robust, providing guidance to all key stakeholder groups in Tanzania.
5. Conclusions
Overall, there are considerable concerns regarding current inappropriate prescribing practices of antibiotics in ambulatory care in Tanzania and the subsequent implications for increasing AMR. As a result, a number of targeted activities are essential among all key stakeholder groups to improve the situation (Table 8). Potential activities include a greater evidence base regarding current prescribing patterns across the sectors alongside possible ways to improve the monitoring of prescribing practices against agreed-upon indicators and guidelines.
Consequently, the development of pertinent and agreed-upon prescribing or quality indicators is an essential next step to improve future prescribing practices. These are likely to be increasingly based on the recently launched AWaRe book and subsequently included as part of planned ASPs. Future ASPs can build on existing examples in Tanzania as well as other LMICs (Table 7 and Table S3). Successful activities to improve future antibiotic prescribing will typically involve coordinated and comprehensive activities among all key stakeholder groups. Educating the community by engaging social media and expanding university curricula to incorporate knowledge of antibiotics and AMR is critical to meet future needs. In addition, there is an urgent need to rapidly address any critical misinformation regarding AMR, AMS, and ASPs. We will continue to monitor the situation given the current urgency and the need to reduce AMR in Tanzania as part of ongoing NAP activities.
Supplementary Materials
The following supporting information can be downloaded at https://www.mdpi.com/article/10.3390/medicina59122195/s1, Table S1. International and national initiatives to reduce AMR; Table S2. Published studies assessing the extent of purchasing of antibiotics without a prescription in Tanzania; Table S3. ASP activities introduced among LMICs in recent years to improve antimicrobial prescribing in ambulatory care and their impact. These include additional references [191,192,193,194,195,196,197,198,199,200,201,202,203,204,205,206].
Author Contributions
Conceptualization: A.M. (Amos Massele), A.C. (Aislinn Cook), C.E.M., B.G., O.M.; methodology, A.M. (Amos Massele), A.C. (Aislinn Cook), A.C. (Audrey Chigome), C.E.M., J.C.M., B.G., O.M.; validation, all Authors; investigation, all authors; resources, A.M. (Amos Massele), B.G., J.C.M.; data curation, all Authors; writing—original draft preparation, A.M. (Amos Massele), B.G.; writing, all authors; visualization, all authors; supervision and project administration, A.M. (Amos Massele), B.G. All authors have read and agreed to the published version of the manuscript.
Institutional Review Board Statement
There was no ethical approval as this study did not involve direct contact with humans. We have used this approach before when undertaking similar studies [64,84,110,115].
Informed Consent Statement
There was no need for patient consent in this study as this was a narrative review of published studies with no direct contact with patients.
Data Availability Statement
We have already referenced all sourced papers and publications.
Conflicts of Interest
The authors declare no conflict of interest.
Funding Statement
This research received no external funding. However, Aislinn Cook and Catrin E Moore are funded by the Welcome Trust (222051/Z/20/Z) for the ADILA project.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
References
- 1.Gautam A. Antimicrobial Resistance: The Next Probable Pandemic. JNMA J. Nepal Med. Assoc. 2022;60:225–228. doi: 10.31729/jnma.7174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Murray C.J., Ikuta K.S., Sharara F., Swetschinski L., Aguilar G.R., Gray A., Han C., Bisignano C., Rao P., Wool E., et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399:629–655. doi: 10.1016/S0140-6736(21)02724-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infect. Drug Resist. 2019;12:3903–3910. doi: 10.2147/IDR.S234610. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.The World Bank Final Report—Drug-Resistant Infections. A Threat to Our Economic Future. 2017. [(accessed on 20 October 2023)]. Available online: http://documents1.worldbank.org/curated/en/323311493396993758/pdf/final-report.pdf.
- 5.Cassini A., Högberg L.D., Plachouras D., Quattrocchi A., Hoxha A., Simonsen G.S., Colomb-Cotinat M., Kretzschmar M.E., Devleesschauwer B., Cecchini M., et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 2019;19:56–66. doi: 10.1016/S1473-3099(18)30605-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.O’Neill J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations—The Review on Antimicrobial Resistance. 2016. [(accessed on 20 October 2023)]. Available online: https://amr-review.org/sites/default/files/160525_Final%20paper_with%20cover.pdf.
- 7.Pulingam T., Parumasivam T., Gazzali A.M., Sulaiman A.M., Chee J.Y., Lakshmanan M., Chin C.F., Sudesh K. Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur. J. Pharm. Sci. 2022;170:106103. doi: 10.1016/j.ejps.2021.106103. [DOI] [PubMed] [Google Scholar]
- 8.WHO . Global Action Plan on Antimicrobial Resistance. WHO; Geneva, Switzerland: 2016. [(accessed on 21 October 2023)]. Available online: https://www.who.int/publications/i/item/9789241509763. [Google Scholar]
- 9.Charani E., Mendelson M., Pallett S.J.C., Ahmad R., Mpundu M., Mbamalu O., Bonaconsa C., Nampoothiri V., Singh S., Peiffer-Smadja N., et al. An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations. Lancet Glob. Health. 2023;11:e466–e474. doi: 10.1016/S2214-109X(23)00019-0. [DOI] [PubMed] [Google Scholar]
- 10.Chua A.Q., Verma M., Hsu L.Y., Legido-Quigley H. An analysis of national action plans on antimicrobial resistance in Southeast Asia using a governance framework approach. Lancet Reg. Health West. Pac. 2021;7:100084. doi: 10.1016/j.lanwpc.2020.100084. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Matee M. Antimicrobial Resistance (AMR) at the Southern Africa Centre for Infectious Disease Surveillance. 2018. [(accessed on 20 October 2023)]. Available online: https://www.openaccessgovernment.org/southern-africa-centre-for-infectious-disease/52063/
- 12.Craig J., Frost I., Sriram A., Nuttall J., Kapoor G., Alimi Y., Varma J. Development of the first edition of African treatment guidelines for common bacterial infections and syndromes. J. Public Health Afr. 2021;12:2009. doi: 10.4081/jphia.2021.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Africa Centres for Disease Control and Prevention and Center for Disease Dynamics, Economics & Policy African Antibiotic Treatment Guidelines for Common Bacterial Infections and Syndromes—Recommended Antibiotic Treatments in Neonatal and Pediatric Patients. 2021. [(accessed on 21 October 2023)]. Available online: https://africaguidelines.cddep.org/wp-content/uploads/2021/11/Quick-Reference-Guide_Peds_English.pdf.
- 14.ASLM The African Society for Laboratory Medicine. [(accessed on 20 October 2023)]. Available online: https://aslm.org/
- 15.Tornimbene B., Eremin S., Abednego R., Abualas E.O., Boutiba I., Egwuenu A., Fuller W., Gahimbare L., Githii S., Kasambara W., et al. Global Antimicrobial Resistance and Use Surveillance System on the African continent: Early implementation 2017–2019. Afr. J. Lab. Med. 2022;11:1594. doi: 10.4102/ajlm.v11i1.1594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.IHME The Burden of Antimicrobial Resistance (AMR) in United Republic of Tanzania. 2023. [(accessed on 22 October 2023)]. Available online: https://www.healthdata.org/sites/default/files/2023-09/Tanzania.pdf.
- 17.Godman B., Egwuenu A., Wesangula E., Schellack N., Kalungia A.C., Tiroyakgosi C., Kgatlwane J., Mwita J.C., Patrick O., Niba L.L., et al. Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future. Expert Opin. Drug Saf. 2022;21:1089–1111. doi: 10.1080/14740338.2022.2106368. [DOI] [PubMed] [Google Scholar]
- 18.Heinzel M., Koenig-Archibugi M. Soft governance against superbugs: How effective is the international regime on antimicrobial resistance? Rev. Int. Organ. 2023;18:1–30. doi: 10.1007/s11558-023-09510-7. [DOI] [Google Scholar]
- 19.Willemsen A., Reid S., Assefa Y. A review of national action plans on antimicrobial resistance: Strengths and weaknesses. Antimicrob. Resist. Infect. Control. 2022;11:90. doi: 10.1186/s13756-022-01130-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Fuller W.L., Aboderin A.O., Yahaya A.A., Adeyemo A.T., Gahimbare L., Kapona O., Hamzat O.T., Bassoum O. Gaps in the implementation of national core elements for sustainable antimicrobial use in the WHO-African region. Front. Antibiot. 2022;1:1047565. doi: 10.3389/frabi.2022.1047565. [DOI] [Google Scholar]
- 21.Sharland M., Gandra S., Huttner B., Moja L., Pulcini C., Zeng M., Mendelson M., Cappello B., Cooke G., Magrini N., et al. Encouraging AWaRe-ness and discouraging inappropriate antibiotic use-the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool. Lancet Infect. Dis. 2019;19:1278–1280. doi: 10.1016/S1473-3099(19)30532-8. [DOI] [PubMed] [Google Scholar]
- 22.Sharland M., Zanichelli V., Ombajo L.A., Bazira J., Cappello B., Chitatanga R., Chuki P., Gandra S., Getahun H., Harbarth S., et al. The WHO essential medicines list AWaRe book: From a list to a quality improvement system. Clin. Microbiol. Infect. 2022;28:1533–1535. doi: 10.1016/j.cmi.2022.08.009. [DOI] [PubMed] [Google Scholar]
- 23.Zanichelli V., Sharland M., Cappello B., Moja L., Getahun H., Pessoa-Silva C., Sati H., van Weezenbeek C., Balkhy H., Mariângela Simão M., et al. TheWHOAWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance. Bull. World Health Organ. 2023;101:290–296. doi: 10.2471/BLT.22.288614. [DOI] [Google Scholar]
- 24.Sulis G., Sayood S., Katukoori S., Bollam N., George I., Yaeger L.H., Chavez M.A., Tetteh E., Yarrabelli S., Pulcini C., et al. Exposure to World Health Organization’s AWaRe antibiotics and isolation of multidrug resistant bacteria: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2022;28:1193–1202. doi: 10.1016/j.cmi.2022.03.014. [DOI] [PubMed] [Google Scholar]
- 25.Klein E.Y., Milkowska-Shibata M., Tseng K.K., Sharland M., Gandra S., Pulcini C., Laxminarayan R. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–2015: An analysis of pharmaceutical sales data. Lancet Infect. Dis. 2021;21:107–115. doi: 10.1016/S1473-3099(20)30332-7. [DOI] [PubMed] [Google Scholar]
- 26.The United Republic Of Tanzania The National Action Plan on Antimicrobial Resistance 2023–2028. Nov, 2022. [(accessed on 20 October 2023)]. Available online: https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/amr-spc-npm/nap-library/the-united-republic-of-tanzania---national-action-plan-2023--2028.pdf?sfvrsn=1a7667b7_6&download=true.
- 27.Sangeda R.Z., Saburi H.A., Masatu F.C., Aiko B.G., Mboya E.A., Mkumbwa S., Bitegeko A., Mwalwisi Y.H., Nkiligi E.A., Chambuso M., et al. National Antibiotics Utilization Trends for Human Use in Tanzania from 2010 to 2016 Inferred from Tanzania Medicines and Medical Devices Authority Importation Data. Antibiotics. 2021;10:1249. doi: 10.3390/antibiotics10101249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Mbwasi R., Mapunjo S., Wittenauer R., Valimba R., Msovela K., Werth B.J., Khea A.M., Nkiligi E.A., Lusaya A., Stergachis A., et al. National Consumption of Antimicrobials in Tanzania: 2017–2019. Front. Pharmacol. 2020;11:585553. doi: 10.3389/fphar.2020.585553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.The United Republic of Tanzania Ministry of Health Community Development Gender Elderly and Children The National Action Plan on Antimicrobial Resistance 2017–2022. 2017. [(accessed on 22 October 2023)]. Available online: https://cdn.who.int/media/docs/default-source/antimicrobial-resistance/the-national-action-plan-on-antimicrobial-resistance-2017-2022.pdf?sfvrsn=31d0867d_1&download=true.
- 30.Sangeda R.Z., Kibona J., Munishi C., Arabi F., Manyanga V.P., Mwambete K.D., Horumpende P.G. Assessment of Implementation of Antimicrobial Resistance Surveillance and Antimicrobial Stewardship Programs in Tanzanian Health Facilities a Year after Launch of the National Action Plan. Front. Public Health. 2020;8:454. doi: 10.3389/fpubh.2020.00454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Frumence G., Mboera L.E.G., Sindato C., Katale B.Z., Kimera S., Metta E., Durrance-Bagale A., Jung A.-S., Mshana S.E., Clark T.G., et al. The Governance and Implementation of the National Action Plan on Antimicrobial Resistance in Tanzania: A Qualitative Study. Antibiotics. 2021;10:273. doi: 10.3390/antibiotics10030273. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Camara N., Moremi N., Mghamba J., Eliakimu E., Shumba E., Ondoa P., Egyir B. Surveillance of antimicrobial resistance in human health in Tanzania: 2016–2021. Afr. J. Lab. Med. 2023;12:2053. doi: 10.4102/ajlm.v12i1.2053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Mashalla Y.J., Sepako E., Setlhare V., Chuma M., Bulang M., Massele A.Y. Availability of guidelines and policy documents for enhancing performance of practitioners at the Primary Health Care (PHC) facilities in Gaborone, Tlokweng and Mogoditshane, Republic of Botswana. J. Public Health Epidemiol. 2016;8:127–135. [Google Scholar]
- 34.Campbell S.M., Meyer J.C., Godman B. Why Compliance to National Prescribing Guidelines is Important Especially across Sub-Saharan Africa and Suggestions for the Future. Biomed. Pharm. Sci. 2021;4:1–7. [Google Scholar]
- 35.Bustreo F., Mshinda H., Hinton R., Hausmann-Muela S., Tanner M. Commentary: Primary health care in Tanzania-Leading the way through innovation. EClinicalMedicine. 2019;13:12–13. doi: 10.1016/j.eclinm.2019.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Kigume R., Maluka S. Decentralisation and Health Services Delivery in 4 Districts in Tanzania: How and Why Does the Use of Decision Space Vary Across Districts? Int. J. Health Policy Manag. 2019;8:90–100. doi: 10.15171/ijhpm.2018.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Gage A.D., Yahya T., Kruk M.E., Eliakimu E., Mohamed M., Shamba D., Roder-DeWan S. Assessment of health facility quality improvements, United Republic of Tanzania. Bull. World Health Organ. 2020;98:849–858a. doi: 10.2471/BLT.20.258145. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yahya T., Mohamed M. Raising a mirror to quality of care in Tanzania: The five-star assessment. Lancet Glob. Health. 2018;6:e1155–e1157. doi: 10.1016/S2214-109X(18)30348-6. [DOI] [PubMed] [Google Scholar]
- 39.Davis A., Lembo T., Laurie E., Mutua E., Loosli K., Nthambi M., Mnzava K., Msoka E.F., Nasuwa F., Melubo M., et al. How public health crises expose systemic, day-to-day health inequalities in low- and-middle income countries: An example from East Africa. Antimicrob. Resist. Infect. Control. 2022;11:34. doi: 10.1186/s13756-022-01071-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Usaid Usaid Medicines, Technologies, and Pharmaceutical Services (Mtaps) Program. 2022. [(accessed on 22 October 2023)]. Available online: https://www.mtapsprogram.org/wp-content/uploads/2022/12/MTaPS-Tanzania-Technical-Brief-Strengthening-Antimicrobial-Stewardship-September-2022.pdf.
- 41.WHO WHO Supports Introduction to Antibiotic Stewardship in Three Hospitals. 2022. [(accessed on 21 October 2023)]. Available online: https://www.afro.who.int/countries/united-republic-of-tanzania/news/who-supports-introduction-antibiotic-stewardship-three-hospitals.
- 42.Olaoye O., Tuck C., Khor W.P., McMenamin R., Hudson L., Northall M., Panford-Quainoo E., Derrick Mawuena Asima D.M., Ashiru-Oredope D. Improving Access to Antimicrobial Prescribing Guidelines in 4 African Countries: Development and Pilot Implementation of an App and Cross-Sectional Assessment of Attitudes and Behaviour Survey of Healthcare Workers and Patients. Antibiotics. 2020;9:555. doi: 10.3390/antibiotics9090555. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Joachim A., Moyo S.J., Nkinda L., Majigo M., Mmbaga E., Mbembati N., Aboud S., Lyamuya E.F. Prevalence of methicillin-resistant Staphylococcus aureus carriage on admission among patients attending regional hospitals in Dar es Salaam, Tanzania. BMC Res. Notes. 2017;10:417. doi: 10.1186/s13104-017-2668-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Mikomangwa W.P., Bwire G.M., Kilonzi M., Mlyuka H., Mutagonda R.F., Kibanga W., Marealle A.I., Minzi O., Mwambete K.D. The Existence of High Bacterial Resistance to Some Reserved Antibiotics in Tertiary Hospitals in Tanzania: A Call to Revisit Their Use. Infect. Drug Resist. 2020;13:1831–1838. doi: 10.2147/IDR.S250158. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Silago V., Mushi M.F., Remi B.A., Mwayi A., Swetala S., Mtemisika C.I., Mshana S.E. Methicillin resistant Staphylococcus aureus causing osteomyelitis in a tertiary hospital, Mwanza, Tanzania. J. Orthop. Surg. Res. 2020;15:95. doi: 10.1186/s13018-020-01618-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Mnyambwa N.P., Mahende C., Wilfred A., Sandi E., Mgina N., Lubinza C., Kahwa A., Petrucka P., Mfinanga S., Ngadaya E., et al. Antibiotic Susceptibility Patterns of Bacterial Isolates from Routine Clinical Specimens from Referral Hospitals in Tanzania: A Prospective Hospital-Based Observational Study. Infect. Drug Resist. 2021;14:869–878. doi: 10.2147/IDR.S294575. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Moremi N., Silago V., Mselewa E.G., Chifwaguzi A.P., Mirambo M.M., Mushi M.F., Matemba L., Seni J., Mshana S.E. Extended-spectrum β-lactamase bla(CTX-M-1) group in gram-negative bacteria colonizing patients admitted at Mazimbu hospital and Morogoro Regional hospital in Morogoro, Tanzania. BMC Res. Notes. 2021;14:77. doi: 10.1186/s13104-021-05495-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Mloka D., Sangeda R.Z., Mwambete K.D., Kamuhabwa A.R. Magnitude of Extended-Spectrum Beta-Lactamase-Producing Gram-Negative and Beta-Lactamase-Producing Gram-Positive Pathogens Isolated from Patients in Dar es Salaam, Tanzania: A Cross-Sectional Study. Cureus. 2022;14:e24451. doi: 10.7759/cureus.24451. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Gidabayda J.G., Philemon R., Abdallah M.S., Saajan A.M., Temu T., Kunjumu I., Mmbaga B.T., Msuya L.J. Prevalence, Aetiology, and Antimicrobial Susceptibility Patterns of Urinary Tract Infection Amongst Children Admitted at Kilimanjaro Christian Medical Centre, Moshi, Tanzania. East Afr. Health Res. J. 2017;1:53–61. doi: 10.24248/eahrj.v1i1.388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Msanga D.R., Silago V., Massoza T., Kidenya B.R., Balandya E., Mirambo M.M., Sunguya B., Mmbaga B.T., Lyamuya E., Bartlet J., et al. High Fecal Carriage of Multidrug Resistant Bacteria in the Community among Children in Northwestern Tanzania. Pathogens. 2022;11:379. doi: 10.3390/pathogens11030379. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Schmider J., Bühler N., Mkwatta H., Lechleiter A., Mlaganile T., Utzinger J., Mzee T., Kazimoto T., Becker S.L. Microbiological Characterisation of Community-Acquired Urinary Tract Infections in Bagamoyo, Tanzania: A Prospective Study. Trop. Med. Infect. Dis. 2022;7:100. doi: 10.3390/tropicalmed7060100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Silago V., Moremi N., Mtebe M., Komba E., Masoud S., Mgaya F.X., Mirambo M.M., Nyawale H.A., Mshana S.E., Matee M.I. Multidrug-Resistant Uropathogens Causing Community Acquired Urinary Tract Infections among Patients Attending Health Facilities in Mwanza and Dar es Salaam, Tanzania. Antibiotics. 2022;11:1718. doi: 10.3390/antibiotics11121718. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Mlugu E.M., Mohamedi J.A., Sangeda R.Z., Mwambete K.D. Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in morogoro, Tanzania: A cross-sectional study. BMC Infect. Dis. 2023;23:660. doi: 10.1186/s12879-023-08641-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Lyus R., Pollock A., Ocan M., Brhlikova P. Registration of antimicrobials, Kenya, Uganda and United Republic of Tanzania, 2018. Bull. World Health Organ. 2020;98:530–538. doi: 10.2471/BLT.19.249433. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Vliegenthart-Jongbloed K., Jacobs J. Not recommended fixed-dose antibiotic combinations in low- and middle-income countries—The example of Tanzania. Antimicrob. Resist. Infect. Control. 2023;12:37. doi: 10.1186/s13756-023-01238-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Duffy E., Ritchie S., Metcalfe S., Van Bakel B., Thomas M.G. Antibacterials dispensed in the community comprise 85%–95% of total human antibacterial consumption. J. Clin. Pharm. Ther. 2018;43:59–64. doi: 10.1111/jcpt.12610. [DOI] [PubMed] [Google Scholar]
- 57.Gasson J., Blockman M., Willems B. Antibiotic prescribing practice and adherence to guidelines in primary care in the Cape Town Metro District, South Africa. S. Afr. Med. J. 2018;108:304–310. doi: 10.7196/SAMJ.2018.v108i4.12564. [DOI] [PubMed] [Google Scholar]
- 58.Brink A.J., Van Wyk J., Moodley V.M., Corcoran C., Ekermans P., Nutt L., Boyles T., Perovic O., Feldman C., Richards G., et al. The role of appropriate diagnostic testing in acute respiratory tract infections: An antibiotic stewardship strategy to minimise diagnostic uncertainty in primary care. S. Afr. Med. J. 2016;106:30–37. doi: 10.7196/SAMJ.2016.v106i6.10857. [DOI] [PubMed] [Google Scholar]
- 59.Makoye K. Antibiotic Misuse Drives Drug-Resistant Bacteria in Tanzania. 2021. [(accessed on 22 October 2023)]. Available online: https://www.aa.com.tr/en/africa/antibiotic-misuse-drives-drug-resistant-bacteria-in-tanzania/2373815.
- 60.Waako P.J., Odoi-adome R., Obua C., Owino E., Tumwikirize W., Ogwal-Okeng J., Anokbonggo W.W., Matowe L., Aupont O. Existing capacity to manage pharmaceuticals and related commodities in East Africa: An assessment with specific reference to antiretroviral therapy. Hum. Resour. Health. 2009;7:21. doi: 10.1186/1478-4491-7-21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Irunde H., Minzi O.M.S., Moshiro C.S., editors. Assessment of rational medicines prescribing in healthcare facilities in four regions of Tanzania. J. Pharm. Pract. Community Med. 2017;3:225–231. doi: 10.5530/jppcm.2017.4.64. [DOI] [Google Scholar]
- 62.Gwimile J.J., Shekalaghe S.A., Kapanda G.N., Kisanga E.R. Antibiotic prescribing practice in management of cough and/or diarrhoea in Moshi Municipality, Northern Tanzania: Cross-sectional descriptive study. Pan Afr. Med. J. 2012;12:103. [PMC free article] [PubMed] [Google Scholar]
- 63.Rogawski E.T., Platts-Mills J.A., Seidman J.C., John S., Mahfuz M., Ulak M., Shrestha S.K., Soofi S.B., Pablo Penataro Yori P.P., Mduma E., et al. Use of antibiotics in children younger than two years in eight countries: A prospective cohort study. Bull. World Health Organ. 2017;95:49–61. doi: 10.2471/BLT.16.176123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Sono T.M., Yeika E., Cook A., Kalungia A., Opanga S.A., Acolatse J.E.E., Sefah I.A., Jelić A.G., Campbell S., Lorenzetti G., et al. Current rates of purchasing of antibiotics without a prescription across sub-saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance. Expert Rev. Anti-Infect. Ther. 2023;21:1025–1055. doi: 10.1080/14787210.2023.2259106. [DOI] [PubMed] [Google Scholar]
- 65.Horumpende P.G., Sonda T.B., van Zwetselaar M., Antony M.L., Tenu F.F., Mwanziva C.E., Shao E.R., Mshana S.E., Mmbaga B.T., Chilongola J.O., et al. Prescription and non-prescription antibiotic dispensing practices in part I and part II pharmacies in Moshi Municipality, Kilimanjaro Region in Tanzania: A simulated clients approach. PLoS ONE. 2018;13:e0207465. doi: 10.1371/journal.pone.0207465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Ndaki P.M., Mushi M.F., Mwanga J.R., Konje E.T., Mugassa S., Manyiri M.W., Mwita S.M., Ntinginya N.E., Mmbaga B.T., Keenan K., et al. Non-prescribed antibiotic dispensing practices for symptoms of urinary tract infection in community pharmacies and accredited drug dispensing outlets in Tanzania: A simulated clients approach. BMC Prim. Care. 2022;23:287. doi: 10.1186/s12875-022-01905-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Ndaki P.M., Mushi M.F., Mwanga J.R., Konje E.T., Ntinginya N.E., Mmbaga B.T., Keenan K., Sabiiti W., Kesby M., Benitez-Paez F., et al. Dispensing Antibiotics without Prescription at Community Pharmacies and Accredited Drug Dispensing Outlets in Tanzania: A Cross-Sectional Study. Antibiotics. 2021;10:1025. doi: 10.3390/antibiotics10081025. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Simon B., Kazaura M. Prevalence and Factors Associated with Parents Self-Medicating Under-Fives with Antibiotics in Bagamoyo District Council, Tanzania: A Cross-Sectional Study. Patient Prefer. Adher. 2020;14:1445–1453. doi: 10.2147/PPA.S263517. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Ndaki P.M., Mwanga J.R., Mushi M.F., Konje E.T., Fredricks K.J., Kesby M., Sandeman A., Mugassa S., Manyiri M.W., Loza O., et al. Practices and motives behind antibiotics provision in drug outlets in Tanzania: A qualitative study. PLoS ONE. 2023;18:e0290638. doi: 10.1371/journal.pone.0290638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70.Hossain M.S., Islam M.F., Arka P.B., Rohman M., Ahmed T.S., Ahammed T., Chowdhury M.A.B., Uddina J. Antibiotic prescription from qualified sources for children with fever/cough: Cross-sectional study from 59 low- and middle-income countries. EClinicalMedicine. 2023;61:102055. doi: 10.1016/j.eclinm.2023.102055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Ngocho J.S., Horumpende P.G., de Jonge M.I., Mmbaga B.T. Inappropriate treatment of community-acquired pneumonia among children under five years of age in Tanzania. Int. J. Infect. Dis. 2020;93:56–61. doi: 10.1016/j.ijid.2020.01.038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Ansah D., Weaver J., Munoz B., Bloch E.M., Coles C.L., Lietman T., West S.K. A Cross-Sectional Study of the Availability of Azithromycin in Local Pharmacies and Associated Antibiotic Resistance in Communities in Kilosa District, Tanzania. Am. J. Trop. Med. Hyg. 2019;100:1105–1109. doi: 10.4269/ajtmh.18-0747. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Bloch E.M., West S.K., Mabula K., Weaver J., Mrango Z., Munoz B., Leitman T., Coles C. Antibiotic Resistance in Young Children in Kilosa District, Tanzania 4 Years after Mass Distribution of Azithromycin for Trachoma Control. Am. J. Trop. Med. Hyg. 2017;97:815–818. doi: 10.4269/ajtmh.17-0022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Ekholuenetale M., Nzoputam C.I., Okonji O.C., Barrow A., Wegbom A.I., Edet C.K. Differentials in the Prevalence of Acute Respiratory Infections Among Under-Five Children: An Analysis of 37 Sub-Saharan Countries. Glob. Pediatr. Health. 2023;10:2333794x231156715. doi: 10.1177/2333794X231156715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Nkinda L., Kilonzi M., Felix F.F., Mutagonda R., Myemba D.T., Mwakawanga D.L., Kibwana U., Njiro B.J., Ndumwa H.P., Mwakalukwa R., et al. Drivers of irrational use of antibiotics among children: A mixed-method study among prescribers and dispensers in Tanzania. BMC Health Serv. Res. 2022;22:961. doi: 10.1186/s12913-022-08359-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Pinto Jimenez C., Pearson M., Hennessey M., Nkereuwem E., Crocker C., Egbujo U., Hendriks J., Smith S., Whanpuch P., Manongi R., et al. Awareness of antibiotic resistance: A tool for measurement among human and animal health care professionals in LMICs and UMICs. J. Antimicrob. Chemother. 2023;78:620–635. doi: 10.1093/jac/dkac424. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Fink G., D’Acremont V., Leslie H.H., Cohen J. Antibiotic exposure among children younger than 5 years in low-income and middle-income countries: A cross-sectional study of nationally representative facility-based and household-based surveys. Lancet Infect. Dis. 2020;20:179–187. doi: 10.1016/S1473-3099(19)30572-9. [DOI] [PubMed] [Google Scholar]
- 78.Acam J., Kuodi P., Medhin G., Makonnen E. Antimicrobial prescription patterns in East Africa: A systematic review. Syst. Rev. 2023;12:18. doi: 10.1186/s13643-022-02152-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Cox J.A., Vlieghe E., Mendelson M., Wertheim H., Ndegwa L., Villegas M.V., Gould I., Hara G.L. Antibiotic stewardship in low- and middle-income countries: The same but different? Clin. Microbiol. Infect. 2017;23:812–818. doi: 10.1016/j.cmi.2017.07.010. [DOI] [PubMed] [Google Scholar]
- 80.Akpan M.R., Isemin N.U., Udoh A.E., Ashiru-Oredope D. Implementation of antimicrobial stewardship programmes in African countries: A systematic literature review. J. Glob. Antimicrob. Resist. 2020;22:317–324. doi: 10.1016/j.jgar.2020.03.009. [DOI] [PubMed] [Google Scholar]
- 81.Siachalinga L., Mufwambi W., Lee I.H. Impact of antimicrobial stewardship interventions to improve antibiotic prescribing for hospital inpatients in Africa: A systematic review and meta-analysis. J. Hosp. Infect. 2022;129:124–143. doi: 10.1016/j.jhin.2022.07.031. [DOI] [PubMed] [Google Scholar]
- 82.Bassetti M., Giacobbe D.R., Vena A., Brink A. Challenges and research priorities to progress the impact of antimicrobial stewardship. Drugs Context. 2019;8:212600. doi: 10.7573/dic.212600. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 83.Yau J.W., Thor S.M., Tsai D., Speare T., Rissel C. Antimicrobial stewardship in rural and remote primary health care: A narrative review. Antimicrob. Resist. Infect. Control. 2021;10:105. doi: 10.1186/s13756-021-00964-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Saleem Z., Godman B., Cook A., Khan M.A., Campbell S.M., Seaton R.A., Siachalinga L., Haseeb A., Amir A., Kurdi A., et al. Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future. Antibiotics. 2022;11:1824. doi: 10.3390/antibiotics11121824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 85.Otieno P.A., Campbell S., Maley S., Obinju Arunga T., Otieno Okumu M. A Systematic Review of Pharmacist-Led Antimicrobial Stewardship Programs in Sub-Saharan Africa. Int. J. Clin. Pract. 2022;2022:3639943. doi: 10.1155/2022/3639943. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Basu S., Copana R., Morales R., Jr Anugulruengkitt S., Puthanakit T., Maramba-Lazarte C., Williams P., Musembi J., Boga M., Issack M., et al. Keeping It Real: Antibiotic Use Problems and Stewardship Solutions in Low- and Middle-income Countries. Pediatr. Infect. Dis. J. 2022;41:S18–S25. doi: 10.1097/INF.0000000000003321. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Dunlea T., Richards S., Lembo T. Healthcare provider-focused antimicrobial stewardship in sub-Saharan Africa: Opportunities and challenges. Trends Microbiol. 2023;31:215–218. doi: 10.1016/j.tim.2022.12.009. [DOI] [PubMed] [Google Scholar]
- 88.Gentilotti E., De Nardo P., Nguhuni B., Piscini A., Damian C., Vairo F., Chaula Z., Mencarini P., Torokaa P., Zumla A., et al. Implementing a combined infection prevention and control with antimicrobial stewardship joint program to prevent caesarean section surgical site infections and antimicrobial resistance: A Tanzanian tertiary hospital experience. Antimicrob. Resist. Infect. Control. 2020;9:69. doi: 10.1186/s13756-020-00740-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.D’Arcy N., Ashiru-Oredope D., Olaoye O., Afriyie D., Akello Z., Ankrah D., Asima D.M., Banda D.C., Barrett S., Brandish C., et al. Antibiotic Prescribing Patterns in Ghana, Uganda, Zambia and Tanzania Hospitals: Results from the Global Point Prevalence Survey (G-PPS) on Antimicrobial Use and Stewardship Interventions Implemented. Antibiotics. 2021;10:1122. doi: 10.3390/antibiotics10091122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 90.Hall J.W., Bouchard J., Bookstaver P.B., Haldeman M.S., Kishimbo P., Mbwanji G., Mwakyula I., Mwasomola D., Seddon M., Shaffer M., et al. The Mbeya Antimicrobial Stewardship Team: Implementing Antimicrobial Stewardship at a Zonal-Level Hospital in Southern Tanzania. Pharmacy. 2020;8:107. doi: 10.3390/pharmacy8020107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 91.Hogendoorn S.K.L., Lhopitallier L., Richard-Greenblatt M., Tenisch E., Mbarack Z., Samaka J., Mlaganile T., Mamin A., Genton B., Kaiser L., et al. Clinical sign and biomarker-based algorithm to identify bacterial pneumonia among outpatients with lower respiratory tract infection in Tanzania. BMC Infect. Dis. 2022;22:39. doi: 10.1186/s12879-021-06994-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Keitel K., Samaka J., Masimba J., Temba H., Said Z., Kagoro F., Mlaganile T., Sangu W., Genton B., D’Acremont V. Safety and Efficacy of C-reactive Protein-guided Antibiotic Use to Treat Acute Respiratory Infections in Tanzanian Children: A Planned Subgroup Analysis of a Randomized Controlled Noninferiority Trial Evaluating a Novel Electronic Clinical Decision Algorithm (ePOCT) Clin. Infect. Dis. 2019;69:1926–1934. doi: 10.1093/cid/ciz080. [DOI] [PubMed] [Google Scholar]
- 93.Shao A.F., Rambaud-Althaus C., Samaka J., Faustine A.F., Perri-Moore S., Swai N., Kahama-Maro J., Mitchell M., Genton B., D’Acremont V. New Algorithm for Managing Childhood Illness Using Mobile Technology (ALMANACH): A Controlled Non-Inferiority Study on Clinical Outcome and Antibiotic Use in Tanzania. PLoS ONE. 2015;10:e0132316. doi: 10.1371/journal.pone.0132316. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Tiroyakgosi C., Matome M., Summers E., Mashalla Y., Paramadhas B.A., Souda S., Malone B., Sinkala F., Kgatlwane J., Godman B., et al. Ongoing initiatives to improve the use of antibiotics in Botswana: University of Botswana symposium meeting report. Expert Rev. Anti Infect. Ther. 2018;16:381–384. doi: 10.1080/14787210.2018.1467756. [DOI] [PubMed] [Google Scholar]
- 95.Mashalla Y., Setlhare V., Massele A., Sepako E., Tiroyakgosi C., Kgatlwane J., Chuma P., Godman B. Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: Findings and implications. Int. J. Clin. Pract. 2017;71:e13042. doi: 10.1111/ijcp.13042. [DOI] [PubMed] [Google Scholar]
- 96.Soleymani F., Godman B., Yarimanesh P., Kebriaeezadeh A. Prescribing patterns of physicians working in both the direct and indirect treatment sectors in Iran; findings and implications. J. Pharm. Health Serv. Res. 2019;10:407–413. doi: 10.1111/jphs.12322. [DOI] [Google Scholar]
- 97.Kamuhabwa A.A.R., Kisoma S. Factors Influencing Prescribing Practices of Medical Practitioners in Public and Private Health Facilities in Dar es Salaam, Tanzania. Trop. J. Pharm. Res. 2015;14:2107–2113. doi: 10.4314/tjpr.v14i11.22. [DOI] [Google Scholar]
- 98.King J.J.C., Powell-Jackson T., Makungu C., Hargreaves J., Goodman C. How much healthcare is wasted? A cross-sectional study of outpatient overprovision in private-for-profit and faith-based health facilities in Tanzania. Health Policy Plan. 2021;36:695–706. doi: 10.1093/heapol/czab039. [DOI] [PubMed] [Google Scholar]
- 99.Roder-DeWan S., Yahya T. Stepwise accreditation in Tanzania: No impact on process quality. Lancet Glob. Health. 2021;9:e1185–e1186. doi: 10.1016/S2214-109X(21)00286-2. [DOI] [PubMed] [Google Scholar]
- 100.Kuwawenaruwa A., Borghi J., Remme M., Mtei G. An assessment of equity in the distribution of non-financial health care inputs across public primary health care facilities in Tanzania. Int. J. Equity Health. 2017;16:124. doi: 10.1186/s12939-017-0620-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Olliaro P., Nkeramahame J., Salami O., Moore C.E., Horgan P., Baiden R., Kukula V., Adjei A., Kapisi J., Hopkins H., et al. Advancing Access to Diagnostic Tools Essential for Universal Health Coverage and Antimicrobial Resistance Prevention: An Overview of Trials in Sub-Saharan Africa. Clin. Infect. Dis. 2023;77((Suppl. 2)):S125–S133. doi: 10.1093/cid/ciad326. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 102.Bwire G.M., Kibwana U.O., Nkinda L., Maganda B.A., Mganga M., Nshau A.B., Williams O., Midega J., Nyankesha E., Scherpbier R.W. Implementation research for promoting access and rational use of antibiotics for children: Lessons learnt from Tanzania. JAC Antimicrob. Resist. 2023;5:dlad045. doi: 10.1093/jacamr/dlad045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Byrne J.A. Improving the peer review of narrative literature reviews. Res. Integr. Peer Rev. 2016;1:12. doi: 10.1186/s41073-016-0019-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.O’Connor R., O’Doherty J., O’Regan A., Dunne C. Antibiotic use for acute respiratory tract infections (ARTI) in primary care; what factors affect prescribing and why is it important? A narrative review. Ir. J. Med. Sci. 2018;187:969–986. doi: 10.1007/s11845-018-1774-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Richards A.R., Linder J.A. Behavioral Economics and Ambulatory Antibiotic Stewardship: A Narrative Review. Clin. Ther. 2021;43:1654–1667. doi: 10.1016/j.clinthera.2021.08.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 106.Tonkin-Crine S., Yardley L., Little P. Antibiotic prescribing for acute respiratory tract infections in primary care: A systematic review and meta-ethnography. J. Antimicrob. Chemother. 2011;66:2215–2223. doi: 10.1093/jac/dkr279. [DOI] [PubMed] [Google Scholar]
- 107.Leung A.K., Hon K.L., Chu W.C. Acute bacterial sinusitis in children: An updated review. Drugs Context. 2020;9:1–11. doi: 10.7573/dic.2020-9-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 108.Rocha V., Estrela M., Neto V., Roque F., Figueiras A., Herdeiro M.T. Educational Interventions to Reduce Prescription and Dispensing of Antibiotics in Primary Care: A Systematic Review of Economic Impact. Antibiotics. 2022;11:1186. doi: 10.3390/antibiotics11091186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 109.Nair M.M., Mahajan R., Burza S., Zeegers M.P. Behavioural interventions to address rational use of antibiotics in outpatient settings of low-income and lower-middle-income countries. Trop. Med. Int. Health. 2021;26:504–517. doi: 10.1111/tmi.13550. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 110.Chigome A., Ramdas N., Skosana P., Cook A., Schellack N., Campbell S., Lorenzetti G., Saleem Z., Godman B., Meyer J.C. A Narrative Review of Antibiotic Prescribing Practices in Primary Care Settings in South Africa and Potential Ways Forward to Reduce Antimicrobial Resistance. Antibiotics. 2023;12:1540. doi: 10.3390/antibiotics12101540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Godman B., Grobler C., Van-De-Lisle M., Wale J., Barbosa W.B., Massele A., Opondo P., Petrova G., Tachkov K., Sefah I., et al. Pharmacotherapeutic interventions for bipolar disorder type II: Addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Expert Opin. Pharmacother. 2019;20:2237–2255. doi: 10.1080/14656566.2019.1684473. [DOI] [PubMed] [Google Scholar]
- 112.Ogunleye O.O., Basu D., Mueller D., Sneddon J., Seaton R.A., Yinka-Ogunleye A.F., Wamboga J., Miljković N., Mwita J.C., Rwegerera G.M., et al. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future. Front. Pharmacol. 2020;11:1205. doi: 10.3389/fphar.2020.01205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 113.Godman B., Basu D., Pillay Y., Mwita J.C., Rwegerera G.M., Anand Paramadhas B.D., Tiroyakgosi C., Okwen P.M., Niba L.L., Nonvignon J., et al. Review of Ongoing Activities and Challenges to Improve the Care of Patients with Type 2 Diabetes Across Africa and the Implications for the Future. Front. Pharmacol. 2020;11:108. doi: 10.3389/fphar.2020.00108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Mwita J.C., Ogunleye O.O., Olalekan A., Kalungia A.C., Kurdi A., Saleem Z., Sneddon J., Godman B. Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications. Int. J. Gen. Med. 2021;14:515–530. doi: 10.2147/IJGM.S253216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Godman B., Egwuenu A., Haque M., Malande O.O., Schellack N., Kumar S., Saleem Z., Sneddon J., Hoxha I., Islam S., et al. Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries. Life. 2021;11:528. doi: 10.3390/life11060528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 116.Wiedenmayer K., Ombaka E., Kabudi B., Canavan R., Rajkumar S., Chilunda F., Sungi S., Stoermer M. Adherence to Standard Treatment Guidelines among Prescribers in Primary Healthcare Facilities in the Dodoma Region of Tanzania. BMC Health Serv. Res. 2021;21:272. doi: 10.1186/s12913-021-06257-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.Sefah I.A., Ogunleye O.O., Essah D.O., Opanga S.A., Butt N., Wamaitha A., Guantai A.N., Chikowe I., Khuluza F., Kibuule D., et al. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries with a Particular Focus on Africa and the Implications. Front. Pharmacol. 2020;11:588106. doi: 10.3389/fphar.2020.588106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Olamijuwon E., Konje E., Kansiime C., Kesby M., Keenan K., Neema S., Asiimwe B., Mshana S.E., Mushi M.F., Loza O., et al. Antibiotic dispensing practices during COVID-19 and implications for antimicrobial resistance (AMR): Parallel mystery client studies in Uganda and Tanzania. Antimicrob. Resist. Infect. Control. 2023;12:10. doi: 10.1186/s13756-022-01199-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Kiragga A.N., Najjemba L., Galiwango R., Banturaki G., Munyiwra G., Iwumbwe I., Atwine J., Ssendiwala C., Natif A., Nakanjako D. Community purchases of antimicrobials during the COVID-19 pandemic in Uganda: An increased risk for antimicrobial resistance. PLoS Glob. Public Health. 2023;3:e0001579. doi: 10.1371/journal.pgph.0001579. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 120.Bednarčuk N., GolićJelić A., Stoisavljević Šatara S., Stojaković N., Marković Peković V., Stojiljković M.P., Popović N., Škrbic R. Antibiotic Utilization during COVID-19: AreWe Over-Prescribing? Antibiotics. 2023;12:308. doi: 10.3390/antibiotics12020308. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 121.Alshaikh F.S., Godman B., Sindi O.N., Seaton R.A., Kurdi A. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis. PLoS ONE. 2022;17:e0272375. doi: 10.1371/journal.pone.0272375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Langford B.J., So M., Raybardhan S., Leung V., Westwood D., MacFadden D.R., Soucy J.-P.R., Daneman N. Bacterial co-infection and secondary infection in patients with COVID-19: A living rapid review and meta-analysis. Clin. Microbiol. Infect. 2020;26:1622–1629. doi: 10.1016/j.cmi.2020.07.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Kimathi G., Kiarie J., Njarambah L., Onditi J., Ojakaa D. A cross-sectional study of antimicrobial use among self-medicating COVID-19 cases in Nyeri County, Kenya. Antimicrob. Resist. Infect. Control. 2022;11:111. doi: 10.1186/s13756-022-01150-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Powell-Jackson T., King J.J.C., Makungu C., Spieker N., Woodd S., Risha P., Goodman C. Infection prevention and control compliance in Tanzanian outpatient facilities: A cross-sectional study with implications for the control of COVID-19. Lancet Glob. Health. 2020;8:e780–e789. doi: 10.1016/S2214-109X(20)30222-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 125.Adebisi Y.A., Jimoh N.D., Ogunkola I.O., Uwizeyimana T., Olayemi A.H., Ukor N.A., Lucero-Prisno D.E., III. The use of antibiotics in COVID-19 management: A rapid review of national treatment guidelines in 10 African countries. Trop. Med. Health. 2021;49:51. doi: 10.1186/s41182-021-00344-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 126.Muro F.J., Lyamuya F.S., Kwobah C., Bollinger J., Bodinayake C.K., Nagahawatte A., Piyasiri B., Kurukulasooriya R., Ali S., Mallya R., et al. Opportunities for Improving Antimicrobial Stewardship: Findings From a Prospective, Multi-Center Study in Three Low- or Middle-Income Countries. Front. Public Health. 2022;10:848802. doi: 10.3389/fpubh.2022.848802. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 127.Rolfe R., Jr., Kwobah C., Muro F., Ruwanpathirana A., Lyamuya F., Bodinayake C., Nagahawatte A., Piyasiri B., Sheng T., Bollinger J., et al. Barriers to implementing antimicrobial stewardship programs in three low- and middle-income country tertiary care settings: Findings from a multi-site qualitative study. Antimicrob. Resist. Infect. Control. 2021;10:60. doi: 10.1186/s13756-021-00929-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Sharland M., Pulcini C., Harbarth S., Zeng M., Gandra S., Mathur S., Magrini N. Classifying antibiotics in the WHO Essential Medicines List for optimal use—Be AWaRe. Lancet Infect. Dis. 2018;18:18–20. doi: 10.1016/S1473-3099(17)30724-7. [DOI] [PubMed] [Google Scholar]
- 129.WHO The WHO AWaRe (Access, Watch, Reserve) Antibiotic Book. 2022. [(accessed on 22 October 2022)]. Available online: https://www.who.int/publications/i/item/9789240062382.
- 130.Emgård M., Mwangi R., Mayo C., Mshana E., Nkini G., Andersson R., Msuya S.E., Lepp M., Muro F., Skovbjerg S. Tanzanian primary healthcare workers’ experiences of antibiotic prescription and understanding of antibiotic resistance in common childhood infections: A qualitative phenomenographic study. Antimicrob. Resist. Infect. Control. 2021;10:94. doi: 10.1186/s13756-021-00952-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 131.Huth P.F.B., Addo M., Daniel T., Groendahl B., Hokororo A., Koliopoulos P., Mshana S., Pretsch L., Schmidt C., Zuechner A., et al. Extensive Antibiotic and Antimalarial Prescription Rate among Children with Acute Febrile Diseases in the Lake Victoria Region, Tanzania. J. Trop. Pediatr. 2021;67:fmaa135. doi: 10.1093/tropej/fmaa135. [DOI] [PubMed] [Google Scholar]
- 132.Kilipamwambu A., Bwire G.M., Myemba D.T., Njiro B.J., Majigo M.V. WHO/INRUD core prescribing indicators and antibiotic utilization patterns among primary health care facilities in Ilala district, Tanzania. JAC Antimicrob. Resist. 2021;3:dlab049. doi: 10.1093/jacamr/dlab049. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.van de Maat J., De Santis O., Luwanda L., Tan R., Keitel K. Primary Care Case Management of Febrile Children: Insights From the ePOCT Routine Care Cohort in Dar es Salaam, Tanzania. Front. Pediatr. 2021;9:626386. doi: 10.3389/fped.2021.626386. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 134.Mabilika R.J., Shirima G., Mpolya E. Prevalence and Predictors of Antibiotic Prescriptions at Primary Healthcare Facilities in the Dodoma Region, Central Tanzania: A Retrospective, Cross-Sectional Study. Antibiotics. 2022;11:1035. doi: 10.3390/antibiotics11081035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 135.Mboya E.A., Davies M.L., Horumpende P.G., Ngocho J.S. Inadequate knowledge on appropriate antibiotics use among clients in the Moshi municipality Northern Tanzania. PLoS ONE. 2020;15:e0239388. doi: 10.1371/journal.pone.0239388. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 136.Keenan K., Fredricks K.J., Al Ahad M.A., Neema S., Mwanga J.R., Kesby M., Mushi M.F., Aduda A., Green D.L., Lynch A.G., et al. Unravelling patient pathways in the context of antibacterial resistance in East Africa. BMC Infect Dis. 2023;23:414. doi: 10.1186/s12879-023-08392-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.King J., Powell-Jackson T., Hargreaves J., Makungu C., Goodman C. Pushy Patients Or Pushy Providers? Effect Of Patient Knowledge On Antibiotic Prescribing In Tanzania. Health Aff. 2022;41:911–920. doi: 10.1377/hlthaff.2021.01782. [DOI] [PubMed] [Google Scholar]
- 138.King J.J.C., Powell-Jackson T., Hargreaves J., Makungu C., Goodman C. Does increased provider effort improve quality of care? Evidence from a standardised patient study on correct and unnecessary treatment. BMC Health Serv. Res. 2023;23:190. doi: 10.1186/s12913-023-09149-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 139.Khalfan M.A., Sasi P.G., Mugusi S.F. The prevalence and pattern of antibiotic prescription among insured patients in Dar es Salaam Tanzania. Pan Afr. Med. J. 2021;40:140. doi: 10.11604/pamj.2021.40.140.29584. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 140.Khalfan M.A., Sasi P., Mugusi S. Factors influencing receipt of an antibiotic prescription among insured patients in Tanzania: A cross-sectional study. BMJ Open. 2022;12:e062147. doi: 10.1136/bmjopen-2022-062147. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 141.Lubwama M., Onyuka J., Ayazika K.T., Ssetaba L.J., Siboko J., Daniel O., Mushi M.F. Knowledge, attitudes, and perceptions about antibiotic use and antimicrobial resistance among final year undergraduate medical and pharmacy students at three universities in East Africa. PLoS ONE. 2021;16:e0251301. doi: 10.1371/journal.pone.0251301. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 142.Ogunnigbo O., Nabiryo M., Atteh M., Muringu E., Olaitan O.J., Rutter V., Ashiru-Oredope D. Exploring the Antimicrobial Stewardship Educational Needs of Healthcare Students and the Potential of an Antimicrobial Prescribing App as an Educational Tool in Selected African Countries. Antibiotics. 2022;11:691. doi: 10.3390/antibiotics11050691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 143.Nkinda L., Mwakawanga D.L., Kibwana U.O., Mikomangwa W.P., Myemba D.T., Sirili N., Mwakalukwa R., Kilonzi M., Sambayi G., Maganda B.A., et al. Implementation of antibiotic stewardship programmes in paediatric patients in regional referral hospitals in Tanzania: Experience from prescribers and dispensers. JAC-Antimicrob. Resist. 2022;4:dlac118. doi: 10.1093/jacamr/dlac118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 144.Mbwambo G., Emidi B., Mgabo M., Sigalla G., Charles Kajeguka D. Community knowledge and attitudes on antibiotic use in Moshi Urban, Northern Tanzania: Findings from a cross sectional study. Afr. J. Microbiol. Res. 2017;11:1018–1026. [Google Scholar]
- 145.Lyimo S.R., Sigalla G.N., Emidi B., Mgabo M.R., Kajeguka D.C. Cross-sectional Survey on Antibiotic Prescription Practices Among Health Care Providers in Rombo District, Northern Tanzania. East Afr. Health Res. J. 2018;2:10–17. doi: 10.24248/eahrj.v2i1.561. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 146.Frumence G., Mboera L.E.G., Katale B.Z., Sindato C., Kimera S., Durrance-Bagale A., Mshana S.E., Clark T.G., Rweyemamu M.M., Legido-Quigley H., et al. Policy actors and human and animal health practitioners’ perceptions of antimicrobial use and resistance in Tanzania: A qualitative study. J. Glob. Antimicrob. Resist. 2021;25:40–47. doi: 10.1016/j.jgar.2021.02.027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 147.Gabriel S., Manumbu L., Mkusa O., Kilonzi M., Marealle A.I., Mutagonda R.F., Mlyuka H., Mikomangwa W.P., Minzi O. Knowledge of use of antibiotics among consumers in Tanzania. JAC Antimicrob. Resist. 2021;3:dlab183. doi: 10.1093/jacamr/dlab183. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 148.Mutagonda R.F., Marealle A.I., Nkinda L., Kibwana U., Maganda B.A., Njiro B.J., Ndumwa H.P., Kilonzi M., Mikomangwa W.P., Mlyuka H.J., et al. Determinants of misuse of antibiotics among parents of children attending clinics in regional referral hospitals in Tanzania. Sci. Rep. 2022;12:4836. doi: 10.1038/s41598-022-08895-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 149.Virhia J., Gilmour M., Russell C., Mutua E., Nasuwa F., Mmbaga B.T., Mshana S.E., Dunlea T., Shirima G., Seni J., et al. “If You Do Not Take the Medicine and Complete the Dose… It Could Cause You More Trouble”: Bringing Awareness, Local Knowledge and Experience into Antimicrobial Stewardship in Tanzania. Antibiotics. 2023;12:243. doi: 10.3390/antibiotics12020243. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Hopkins H., Bruxvoort K.J., Cairns M.E., Chandler C.I., Leurent B., Ansah E.K., Baiden F., Baltzell K.A., Björkman A., Burchett H.E.D., et al. Impact of introduction of rapid diagnostic tests for malaria on antibiotic prescribing: Analysis of observational and randomised studies in public and private healthcare settings. BMJ. 2017;356:j1054. doi: 10.1136/bmj.j1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 151.Rambaud-Althaus C., Shao A., Samaka J., Swai N., Perri S., Kahama-Maro J., Mitchell M., D’Acremont V., Genton B. Performance of HealthWorkers Using an Electronic Algorithm for the Management of Childhood Illness in Tanzania: A Pilot Implementation Study. Am. J. Trop. Med. Hyg. 2017;96:249–257. doi: 10.4269/ajtmh.15-0395. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 152.Keitel K., Kagoro F., Samaka J., Masimba J., Said Z., Temba H., Mlaganile T., Sangu W., Rambaud-Althaus C., Gervaix A., et al. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial. PLoS Med. 2017;14:e1002411. doi: 10.1371/journal.pmed.1002411. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 153.Gustafsson L.L., Wettermark B., Godman B., Andersén-Karlsson E., Bergman U., Hasselström J., Hensjö L.-O., Hjemdahl P., Jägre I., Julander M., et al. The ‘wise list—A comprehensive concept to select, communicate and achieve adherence to recommendations of essential drugs in ambulatory care in Stockholm. Basic Clin. Pharmacol. Toxicol. 2011;108:224–233. doi: 10.1111/j.1742-7843.2011.00682.x. [DOI] [PubMed] [Google Scholar]
- 154.Björkhem-Bergman L., Andersén-Karlsson E., Laing R., Diogene E., Melien O., Jirlow M., Malmström R.E., Vogler S., Godman B., Gustafsson L.L. Interface management of pharmacotherapy. Joint hospital and primary care drug recommendations. Eur. J. Clin. Pharmacol. 2013;69((Suppl. S1)):73–78. doi: 10.1007/s00228-013-1497-5. [DOI] [PubMed] [Google Scholar]
- 155.Eriksen J., Gustafsson L.L., Ateva K., Bastholm-Rahmner P., Ovesjö M.L., Jirlow M., Juhasz-Haverinen M., Lärfars G., Malmström R., Wettermark B., et al. High adherence to the ‘Wise List’ treatment recommendations in Stockholm: A 15-year retrospective review of a multifaceted approach promoting rational use of medicines. BMJ Open. 2017;7:e014345. doi: 10.1136/bmjopen-2016-014345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 156.King J.J.C., Powell-Jackson T., Makungu C., Spieker N., Risha P., Mkopi A., Goodman C. Effect of a multifaceted intervention to improve clinical quality of care through stepwise certification (SafeCare) in health-care facilities in Tanzania: A cluster-randomised controlled trial. Lancet Glob. Health. 2021;9:e1262–e1272. doi: 10.1016/S2214-109X(21)00228-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 157.Fadare J.O., Bankole I., Babatola A., Simeon Olatunya O., Aina F., Godman B. Adherence to WHO Criteria on Drug Promotion Literature: An Exploratory Study From a Tertiary Healthcare Facility in South-West Nigeria. Hosp. Pharm. 2023;58:62–69. doi: 10.1177/00185787221123217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 158.Ogunleye O.O., Fadare J.O., Yinka-Ogunleye A.F., Anand Paramadhas B.D., Godman B. Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital. Hosp. Pract. 2019;47:53–58. doi: 10.1080/21548331.2018.1475997. [DOI] [PubMed] [Google Scholar]
- 159.Fadare J.O., Oshikoya K.A., Ogunleye O.O., Desalu O.O., Ferrario A., Enwere O.O., Adeoti A., Sunmonu T.A., Massele A., Baker A., et al. Drug promotional activities in Nigeria: Impact on the prescribing patterns and practices of medical practitioners and the implications. Hosp. Pract. 2018;46:77–87. doi: 10.1080/21548331.2018.1437319. [DOI] [PubMed] [Google Scholar]
- 160.Kiggundu R., Lusaya E., Seni J., Waswa J.P., Kakooza F., Tjipura D., Kikule K., Muiva C., Joshi M.P., Stergachis A., et al. Identifying and addressing challenges to antimicrobial use surveillance in the human health sector in low- and middle-income countries: Experiences and lessons learned from Tanzania and Uganda. Antimicrob. Resist. Infect. Control. 2023;12:9. doi: 10.1186/s13756-023-01213-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 161.Niaz Q., Godman B., Massele A., Campbell S., Kurdi A., Kagoya H.R., Kibuule D. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: Findings and implications. Int. J. Qual. Health Care. 2019;31:338–345. doi: 10.1093/intqhc/mzy172. [DOI] [PubMed] [Google Scholar]
- 162.Etando A., Amu A.A., Haque M., Schellack N., Kurdi A., Alrasheedy A.A., Timoney A., Mwita J.C., Rwegerera G.M., Patrick O., et al. Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future. Healthcare. 2021;9:1722. doi: 10.3390/healthcare9121722. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 163.Kuwawenaruwa A., Wyss K., Wiedenmayer K., Metta E., Tediosi F. The effects of medicines availability and stock-outs on household’s utilization of healthcare services in Dodoma region, Tanzania. Health Policy Plan. 2020;35:323–333. doi: 10.1093/heapol/czz173. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 164.Binyaruka P., Borghi J. Improving quality of care through payment for performance: Examining effects on the availability and stock-out of essential medical commodities in Tanzania. Trop. Med. Int. Health. 2017;22:92–102. doi: 10.1111/tmi.12809. [DOI] [PubMed] [Google Scholar]
- 165.Acharya K.P., Subedi D. Use of Social Media as a Tool to Reduce Antibiotic Usage: A Neglected Approach to Combat Antimicrobial Resistance in Low and Middle Income Countries. Front. Public Health. 2020;8:558576. doi: 10.3389/fpubh.2020.558576. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 166.Joseph A.M., Fernandez V., Kritzman S., Eaddy I., Cook O.M., Lambros S., Silva C.E.J., Arguelles D., Abraham C., Dorgham N., et al. COVID-19 Misinformation on Social Media: A Scoping Review. Cureus. 2022;14:e24601. doi: 10.7759/cureus.24601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 167.Stewart R., Madonsela A., Tshabalala N., Etale L., Theunissen N. The importance of social media users’ responses in tackling digital COVID-19 misinformation in Africa. Digit. Health. 2022;8:20552076221085070. doi: 10.1177/20552076221085070. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 168.Schellack N., Strydom M., Pepper M.S., Herd C.L., Hendricks C.L., Bronkhorst E., Meyer J.C., Padayachee N., Bangalee V., Truter I., et al. Social Media and COVID-19; Perceptions and Public Deceptions of Ivermectin, Colchicine and Hydroxychloroquine: Lessons for Future Pandemics. Antibiotics. 2022;11:445. doi: 10.3390/antibiotics11040445. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 169.Parveen S., Garzon-Orjuela N., Amin D., McHugh P., Vellinga A. Public Health Interventions to Improve Antimicrobial Resistance Awareness and Behavioural Change Associated with Antimicrobial Use: A Systematic Review Exploring the Use of Social Media. Antibiotics. 2022;11:669. doi: 10.3390/antibiotics11050669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 170.Mokoena T.T.W., Schellack N., Brink A.J. Driving antibiotic stewardship awareness through the minibus-taxi community across the Tshwane District, South Africa-a baseline evaluation. JAC Antimicrob. Resist. 2021;3:dlab106. doi: 10.1093/jacamr/dlab106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 171.Haenssgen M.J., Xayavong T., Charoenboon N., Warapikuptanun P., Khine Zaw Y. The Consequences of AMR Education and Awareness Raising: Outputs, Outcomes, and Behavioural Impacts of an Antibiotic-Related Educational Activity in Lao PDR. Antibiotics. 2018;7:95. doi: 10.3390/antibiotics7040095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 172.Charoenboon N., Haenssgen M.J., Warapikuptanun P., Xayavong T., Khine Zaw Y. Translating antimicrobial resistance: A case study of context and consequences of antibiotic-related communication in three northern Thai villages. Palgrave Commun. 2019;5:23. doi: 10.1057/s41599-019-0226-9. [DOI] [Google Scholar]
- 173.Miller B.J., Carson K.A., Keller S. Educating Patients on Unnecessary Antibiotics: Personalizing Potential Harm Aids Patient Understanding. J. Am. Board Fam. Med. 2020;33:969–977. doi: 10.3122/jabfm.2020.06.200210. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 174.Saleem Z., Hassali M.A., Godman B., Fatima M., Ahmad Z., Sajid A., Rehman I.U., Nadeem M.U., Javaid Z., Malik M., et al. Sale of WHO AWaRe groups antibiotics without a prescription in Pakistan: A simulated client study. J. Pharm. Policy Pract. 2020;13:26. doi: 10.1186/s40545-020-00233-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 175.Malik F., Figueras A. Continuous rise in cephalosporin and fluoroquinolone consumption in Pakistan: A 5 year analysis (2014-18) JAC Antimicrob. Resist. 2019;1:dlz063. doi: 10.1093/jacamr/dlz063. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 176.Sulis G., Daniels B., Kwan A., Gandra S., Daftary A., Das J., Pai M. Antibiotic overuse in the primary health care setting: A secondary data analysis of standardised patient studies from India, China and Kenya. BMJ Glob. Health. 2020;5:e003393. doi: 10.1136/bmjgh-2020-003393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 177.Ahiabu M.A., Tersbøl B.P., Biritwum R., Bygbjerg I.C., Magnussen P. A retrospective audit of antibiotic prescriptions in primary health-care facilities in Eastern Region, Ghana. Health Policy Plan. 2016;31:250–258. doi: 10.1093/heapol/czv048. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 178.Mekuria L.A., de Wit T.F., Spieker N., Koech R., Nyarango R., Ndwiga S., Fenenga C.J., Ogink A., Schultsz C., van’t Hoog A. Analyzing data from the digital healthcare exchange platform for surveillance of antibiotic prescriptions in primary care in urban Kenya: A mixed-methods study. PLoS ONE. 2019;14:e0222651. doi: 10.1371/journal.pone.0222651. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 179.Kunda M., Gorases L. An Investigation of Antibiotic Prescribing in Patients with Upper Respiratory Tract Infections (Urtis) at Katutura Health Centre, Windhoek, Namibia. Single Cell Biol. 2015;4:122. doi: 10.4172/2168-9431.1000122. [DOI] [Google Scholar]
- 180.Sefah I.A., Essah D.O., Kurdi A., Sneddon J., Alalbila T.M., Kordorwu H., Godman B. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: Findings and implications for the future. JAC Antimicrob. Resist. 2021;3:dlab080. doi: 10.1093/jacamr/dlab080. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 181.Sié A., Ouattara M., Bountogo M., Dah C., Compaoré G., Boudo V., Lebas E., Brogdon J., Nyatigo F., Arnold B.F., et al. Indication for Antibiotic Prescription Among Children Attending Primary Healthcare Services in Rural Burkina Faso. Clin. Infect. Dis. 2021;73:1288–1291. doi: 10.1093/cid/ciab471. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 182.Lanyero H., Eriksen J., Obua C., Stålsby Lundborg C., Nanzigu S., Katureebe A., Kalyango J.N., Ocan M. Use of antibacterials in the management of symptoms of acute respiratory tract infections among children under five years in Gulu, northern Uganda: Prevalence and determinants. PLoS ONE. 2020;15:e0235164. doi: 10.1371/journal.pone.0235164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 183.Allwell-Brown G., Namugambe J.S., Ssanyu J.N., Johansson E.W., Hussain-Alkhateeb L., Strömdahl S., Mårtensson A., Kitutu F.E. Patterns and contextual determinants of antibiotic prescribing for febrile under-five outpatients at primary and secondary healthcare facilities in Bugisu, Eastern Uganda. JAC Antimicrob. Resist. 2022;4:dlac091. doi: 10.1093/jacamr/dlac091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 184.Owusu H., Thekkur P., Ashubwe-Jalemba J., Hedidor G.K., Corquaye O., Aggor A., Vu H.T.L., Wertheim H.F.L., van Doorn R., Lewycka S. Compliance to Guidelines in Prescribing Empirical Antibiotics for Individuals with Uncomplicated Urinary Tract Infection in a Primary Health Facility of Ghana, 2019–2021. Int. J. Environ. Res. Public Health. 2022;19:12413. doi: 10.3390/ijerph191912413. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 185.Obakiro S.B., Napyo A., Wilberforce M.J., Adongo P., Kiyimba K., Anthierens S., Kostyaneve T., Waako P., Van Royend P. Are antibiotic prescription practices in Eastern Uganda concordant with the national standard treatment guidelines? A cross-sectional retrospective study. J. Glob. Antimicrob. Resist. 2022;29:513–519. doi: 10.1016/j.jgar.2021.11.006. [DOI] [PubMed] [Google Scholar]
- 186.Hamilton D., Bugg I. Improving antimicrobial stewardship in the outpatient department of a district general hospital in Sierra Leone. BMJ Open Qual. 2018;7:e000495. doi: 10.1136/bmjoq-2018-000495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 187.Godman B., Fadare J., Kwon H.Y., Dias C.Z., Kurdi A., Dias Godói I.P., Kibuule D., Hoxha I., Opanga S., Saleem Z., et al. Evidence-based public policy making for medicines across countries: Findings and implications for the future. J. Comp. Eff. Res. 2021;10:1019–1052. doi: 10.2217/cer-2020-0273. [DOI] [PubMed] [Google Scholar]
- 188.Kwon H.Y., Kim H., Godman B., Reich M.R. The impact of South Korea’s new drug-pricing policy on market competition among off-patent drugs. Expert Rev. Pharmacoecon. Outcomes Res. 2015;15:1007–1014. doi: 10.1586/14737167.2015.1083425. [DOI] [PubMed] [Google Scholar]
- 189.Abuelkhair M., Abdu S., Godman B., Fahmy S., Malmström R.E., Gustafsson L.L. Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: Case history from Abu Dhabi. Expert Rev. Pharmacoecon. Outcomes Res. 2012;12:115–124. doi: 10.1586/erp.11.90. [DOI] [PubMed] [Google Scholar]
- 190.Epps A., Albury C., Van Hecke O. Exploring Primary Care Clinicians’ Views about How Best to Implement a Potential Trial around Point-of-Care Tests for Common Infections in South Africa. Diagnostics. 2021;11:2100. doi: 10.3390/diagnostics11112100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 191.Mboya E.A., Sanga L.A., Ngocho J.S. Irrational use of antibiotics in the Moshi Municipality Northern Tanzania: A cross sectional study. Pan Afr. Med. J. 2018;31:165. doi: 10.11604/pamj.2018.31.165.15991. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 192.Poyongo B.P., Sangeda R.Z. Pharmacists’ Knowledge, Attitude and Practice Regarding the Dispensing of Antibiotics without Prescription in Tanzania: An Explorative Cross-Sectional Study. Pharmacy. 2020;8:238. doi: 10.3390/pharmacy8040238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 193.Mabilika R.J., Mpolya E., Shirima G. Prevalence and predictors of self-medication with antibiotics in selected urban and rural districts of the Dodoma region, Central Tanzania: A cross-sectional study. Antimicrob. Resist. Infect. Control. 2022;11:86. doi: 10.1186/s13756-022-01124-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 194.Zhang Z., Dawkins B., Hicks J.P., Walley J.D., Hulme C., Elsey H., Deng S., Lin M., Zeng J., Wei X. Cost-effectiveness analysis of a multi-dimensional intervention to reduce inappropriate antibiotic prescribing for children with upper respiratory tract infections in China. Trop. Med. Int. Health. 2018;23:1092–1100. doi: 10.1111/tmi.13132. [DOI] [PubMed] [Google Scholar]
- 195.Wei X., Zhang Z., Hicks J.P., Walley J.D., King R., Newell J.N., Yin J., Zeng J., Guo Y., Lin M., et al. Long-term outcomes of an educational intervention to reduce antibiotic prescribing for childhood upper respiratory tract infections in rural China: Follow-up of a cluster-randomised controlled trial. PLoS Med. 2019;16:e1002733. doi: 10.1371/journal.pmed.1002733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 196.Dehn Lunn A. Reducing inappropriate antibiotic prescribing in upper respiratory tract infection in a primary care setting in Kolkata, India. BMJ Open Qual. 2018;7:e000217. doi: 10.1136/bmjoq-2017-000217. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 197.Egger J.R., Stankevitz K., Korom R., Angwenyi P., Sullivan B., Wang J., Hatfield S., Smith E., Popli K., Gross J. Evaluating the effects of organizational and educational interventions on adherence to clinical practice guidelines in a low-resource primary-care setting in Kenya. Health Policy Plan. 2017;32:761–768. doi: 10.1093/heapol/czx004. [DOI] [PubMed] [Google Scholar]
- 198.Korom R.R., Onguka S., Halestrap P., McAlhaney M., Adam M. Brief educational interventions to improve performance on novel quality metrics in ambulatory settings in Kenya: A multi-site pre-post effectiveness trial. PLoS ONE. 2017;12:e0174566. doi: 10.1371/journal.pone.0174566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 199.Kleczka B., Kumar P., Njeru M.K., Musiega A., Wekesa P., Rabut G., Marx M. Using rubber stamps and mobile phones to help understand and change antibiotic prescribing behaviour in private sector primary healthcare clinics in Kenya. BMJ Glob. Health. 2019;4:e001422. doi: 10.1136/bmjgh-2019-001422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 200.Tay K.H., Ariffin F., Sim B.L., Chin S.Y., Sobry A.C. Multi-Faceted Intervention to Improve the Antibiotic Prescriptions among Doctors for Acute URI and Acute Diarrhoea Cases: The Green Zone Antibiotic Project. Malays. J. Med. Sci. MJMS. 2019;26:101–109. doi: 10.21315/mjms2019.26.4.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 201.Brinkmann I., Kibuule D. Effectiveness of antibiotic stewardship programmes in primary health care settings in developing countries. Res. Soc. Adm. Pharm. 2020;16:1309–1313. doi: 10.1016/j.sapharm.2019.03.008. [DOI] [PubMed] [Google Scholar]
- 202.Blaauw D., Lagarde M. New Study Finds Very High Rate of Unnecessary Antibiotic Prescribing in SA. 2019. [(accessed on 20 October 2023)]. Available online: https://www.wits.ac.za/news/latest-news/research-news/2019/2019-03/new-study-finds-very-high-rate-of-unnecessary-antibiotic-prescribing-in-sa-.html.
- 203.Van Hecke O., Butler C., Mendelson M., Tonkin-Crine S. Introducing new point-of-care tests for common infections in publicly funded clinics in South Africa: A qualitative study with primary care clinicians. BMJ Open. 2019;9:e029260. doi: 10.1136/bmjopen-2019-029260. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 204.De Vries E., Johnson Y., Willems B., Bedeker W., Ras T., Coetzee R., Tembo Y., Brink A. Improving primary care antimicrobial stewardship by implementing a peer audit and feedback intervention in Cape Town community healthcare centres. S. Afr. Med. J. 2022;112:812–818. doi: 10.7196/SAMJ.2022.v112i10.16397. [DOI] [PubMed] [Google Scholar]
- 205.Masetla M.A., Ntuli P.N., Abraham V., Godman B., Witika B.A., Mudenda S., Skosana P.P. Antimicrobial Stewardship for Outpatients with Chronic Bone and Joint Infections in the Orthopaedic Clinic of an Academic Tertiary Hospital, South Africa. Antibiotics. 2023;12:1142. doi: 10.3390/antibiotics12071142. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 206.Hoa N.Q., Thi Lan P., Phuc H.D., Chuc N.T.K., Stalsby Lundborg C. Antibiotic prescribing and dispensing for acute respiratory infections in children: Effectiveness of a multi-faceted intervention for health-care providers in Vietnam. Glob. Health Action. 2017;10:1327638. doi: 10.1080/16549716.2017.1327638. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
We have already referenced all sourced papers and publications.